Category: ACN Newswire

TAIPEI, TW, Apr 15, 2026 - (ACN Newswire via SeaPRwire.com) - OBI Pharma, Inc. (TPEx:4174.TWO) today announced its presence at AACR 2026, highlighted by ten poster presentations, showcasing the transformative potential of the GlycOBI® platform. Conventional ADCs often face limitations due to random conjugation, resulting in heterogeneous Drug-to-Antibody Ratios (DAR), suboptimal stability, and narrow therapeutic windows. In contrast, the OBI site-specific glycan-based technology enables a highly homogeneous DAR, translating into improved PK/PD profiles, and reduced off-target toxicity, as demonstrated by OBI's lead programs, OBI-902 and OBI-904.We are further advancing precision oncology through our next-generation bispecific (OBI-201) and bispecific, dual-payload (OBI-221) ADCs. These "biology - driven" molecules are designed to overcome tumor heterogeneity and multi-drug resistance-key challenges in current cancer treatment. By incorporating both the GlycOBI® and GlycOBI DUO® platforms, OBI is developing novel and differentiated therapeutics addressing the unmet medical need for patients with difficult-to-treat solid tumors. Additionally, OBI's robust ADC conjugation platform has proven to consistently deliver product quality and scalability, while enabling expansion into next-generation modalities, including degrader-antibody conjugates (DACs).These data will be presented at the American Association of Cancer Research (AACR) Annual Meeting from April 17 to 22, 2026 in San Diego, CA. (USA)."At OBI, we make better ADCs," said Dr. Ya-Chi Chen, Chief Scientific Officer OBI Pharma. "Our goal is to deliver therapies that not only target tumors more effectively and precisely, but also reduce side effects, giving patients potentially life-changing treatment options."Monday, April 20, 2026 (9:00 AM - 12:00 PM)Title: Overcoming Resistance with OBI-902: Preclinical Evaluation of a Next-Generation TROP2 ADC1Authors: Ren-Yu Hsu, Chi-Huan Lu, Chi-Sheng Shia, Jing-Rong Huang, Hsin-Shan Wu, Lu-Tzu Chen, Jhih-Jie Yang, Tzu-Min Yen, Jyy-Shiuan Tu, Yu-Hsuan Tsao, Ya-Chi Chen. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO. ET07.01 - Quantitative Pharmacology and Translational ModelingLocation: Poster Section 17Poster Board Number: 6Abstract Presentation Number: 1818Title: OBI-904, a Next-Generation Nectin-4-Targeting Exatecan ADC, Demonstrates Enhanced Cytotoxicity and Overcomes Enfortumab Vedotin Resistance2Authors :Yuan-Liang Wang, Chi-Huan Lu, Woan-Eng Chan, Shin-Jin Lin, Ting-Yu Chang, Hong-Syuan Lin, Wei-Jhen Huang, Ya-Chi Chen. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.ET02.02 - Antibody-Drug Conjugates and Linker Engineering 2Location: Poster Section 13Poster Board Number: 26Abstract Presentation Number: 1729Title: OBI-904, a Glycan-based Site specific Nectin-4-Targeted ADC, Demonstrates Potent and Durable Antitumor Activity with an Improved PK Profile and Overcoming EV-Resistance in Non-Clinical Studies3Authors: Chi-Huan Lu, Ren-Yu Hsu, Jing-Jie Ciou, Tzu Min Yen, Jyy-Shiuan Tu, Yu-Hsuan Tsao, Jing-Rong Huang, Ya-Chi Chen. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET07.01 - Quantitative Pharmacology and Translational ModelingLocation: Poster Section 17Poster Board Number: 7Abstract Presentation Number: 1819Title: The MET/HER3 Antibody-Drug Conjugate with Dual Payload: A Dual-Target Approach to Eliminate Tumor Escape Mechanisms5Authors: Yuan-Liang Wang, Chi-Huan Lu, Woan-Eng Chan, Ting-Yu Chang, Hong-Syuan Lin, Cheng-Yen Wei, Shin-Jin Lin, Lu-Tzu Lu, Meng-Hsin Liu, Wei-Jhen Huang, Ya-Chi Chen. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.CL.0705 - Targeted Antigen Therapies and ImmunityLocation: Poster Section 49Poster Board Number: 17Abstract Presentation Number: 2665Title: Guide-effector bsADCs: Driving co-endocytosis for enhanced payload delivery6Authors: Wei-Jhen Huang, Woan Eng Chan, Meng-Hsin Liu, Yueh Chin Wu, Ya-Chi Chen .OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET02.02 - Antibody-Drug Conjugates and Linker Engineering 2Location: Poster Section 13Poster Board Number : 27Abstract Presentation Number: 1730Title: Hydrophilicity-Enhanced Linker Technology Enables Site-Specific Degrader-Antibody Conjugates with Improved Stability and Enhanced Activity7Authors: Yu-Hung Chen, Wei-Chien Tang, Chi-Dian Lu, Hung-Yi Lin, Wei-Jhen Huang, Nan-Hsuan Wang, Ya-Chi Chen, Teng-Yi Huang. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET02.02 - Antibody-Drug Conjugates and Linker Engineering 2Location: Poster Section 13Poster Board Number: 28Abstract Presentation Number: 1731Title: Cell-based payload release highlights design, site, and cell-dependent ratio shifts in dual-payload ADCs8Authors: Nan-Hsuan Wang, Wei-Han Lee, Evelyn He, Li Chuan Huang, Yu-Chao Huang, David Teng-Yi Huang, Ya-Chi Chen. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.CH01.06 - Antibodies, Antibody-Drug Conjugates, and Nucleic AcidsLocation: Poster Section 38Poster Board Number: 5Abstract Presentation Number: 2397Monday, April 20, 2026 (2:00 PM - 5:00 PM)Title:TROP2 Upregulation and Interaction with HER2 Mediate Trastuzumab Resistance4Authors: Yuan-Liang Wang, Chi-Huan Lu, Cheng-Yen Wei, Jye-Yu Huang, Woan-Eng Chan, Lu-Tzu Chen, Ya-Chi Chen. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET03.06 Drug Resistance 1: Antibodies and ADCsLocation: Poster Section 12Poster Board Number: 18Abstract Presentation Number: 2972Tuesday, April 21, 2026 (9:00 AM - 12:00 PM)Title: Glycan-based site specific ADC Achieves Sustained Tumor Control through Improved Payload Delivery and Immune Activation9Authors: Liu Chih-Chun, Tsai Yi-Chien, Huang Jing-Rong, Lo Fei-Yun, Pei Yu, Hsu Ren-Yu, Tu Tzu-Hsuan, Chen Ya-Chi. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.IM02.04 - Adaptive Immunity in CancerLocation: Poster Section 6Poster Board Number: 2Abstract Presentation Number: 4234Title: Advancing ADC therapeutics with next-generation site-specific glycan conjugation and dual-payload flexibility10Authors: Wei-Chien Tang, Yu-Hung Chen, Chih-Kang Chang, Ting-Wei Liu, Hung-Yi Lin, Wei-Jhen Huang, Chi-Huan Lu, Ren-Yu Hsu, Nan-Hsuan Wang, Ya-Chi Chen,Teng-Yi Huang. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.ET02.03 - Antibody-Drug Conjugates and Linker Engineering 3Location: Poster Section 12Poster Board Number: 1Abstract Presentation Number: 4423The e-posters will be available for browsing at the AACR virtual meeting platform beginning at 12:00 PM PT on April 17, as well as on the OBI Pharma website (www.obipharma.com) beginning on April 18.1 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/45832 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/53853 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/45884 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/50305 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/40516 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/54007 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/54018 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/64749 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/131110 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/5403About OBI PharmaOBI Pharma is a clinical-stage global oncology company established in 2002 and headquartered in Taiwan. Together with its subsidiary OBI Pharma USA, Inc., the company is dedicated to developing innovative cancer therapeutics to provide new treatment options for patients with urgent medical needs.OBI's research efforts center on novel antibody-drug conjugates (ADC). Through its patented next-generation conjugation technology platform, Obrion™, OBI has established diverse ADC design modalities. The platform integrates proprietary conjugation and linker technologies, including GlycOBI®, GlycOBI DUO®, EndoSymeOBI®, HYPrOBI®, and the novel irreversible cysteine-conjugation technology ThiOBI® , to advance next-generation ADC solutions. OBI has developed a next-generation suite of ADC programs. These include monospecific ADCs such as OBI-902 (TROP2), which is under Ph1 clinical evaluation, and OBI-904 (Nectin-4); a bispecific single-payload ADC, OBI-201 (HER2 x TROP2); and a bispecific dual-payload ADC, OBI-221 (cMET x HER3). To broaden the applicability of the HYPrOBI® linker technology, OBI has further developed the ThiOBI® technology to enable irreversible cysteine-based conjugation. In addition to its ADC programs, OBI's assets include OBI-3424, a first-in-class AKR1C3-targeted small-molecule prodrug that selectively releases a potent DNA-alkylating agent in the presence of the aldo-keto reductase 1C3 enzyme, which is highly expressed in certain tumors. Additional information can be found at www.obipharma.com.About OBI-902 and OBI-992OBI-902 is a TROP2-targeted antibody-drug conjugate (ADC) that carries a potent topoisomerase I inhibitor payload to kill tumor cells with a drug-antibody ratio (DAR) of 4. TROP2 is highly expressed in a variety of solid tumors such as breast, lung, biliary, bile duct (cholangiocarcinoma), ovarian, gastric, and many other cancer types, rendering it an ideal target for cancer therapy.OBI-902 is a novel site-specific glycan-conjugated ADC using OBI's proprietary GlycOBI® platform, which provides improved stability and enhanced hydrophilicity. OBI-902 demonstrated remarkable antitumor efficacy across multiple tumors, including NSCLC, triple-negative breast cancer (TNBC), and gastric cancer, improved pharmacokinetic characteristics, and a favorable safety profile in various animal models. The IND of OBI-902 was cleared by the United States Food and Drug Administration (US FDA) on April 30, 2025, received Orphan Drug Designation (ODD) from the US FDA for cholangiocarcinoma on Nov. 16, 2025, and gastric cancer (GC), including gastroesophageal junction cancer (GEJC) on December 5, 2025.The Phase 1/2 Study (NCT07124117) is ongoing, with completion of the Phase 1a portion targeted for 1H 2027.OBI-992 is a TROP2-targeted antibody-drug conjugate (ADC) that carries a potent topoisomerase I inhibitor payload with drug-to-antibody ratio of 4 (DAR 4) via a cysteine conjugated, hydrophilic and enzyme-cleavable linker. OBI-992 remains stable in circulation and delivers this cytotoxic payload to TROP2-expressing tumor cells, leading to tumor cell death while avoiding off-target toxicities.The US FDA cleared the IND application for OBI-992 in Jan 2024 and subsequently granted Orphan Drug Designation for the treatment of gastric cancer, including GEJC in Aug 2024. The Phase 1/2 Study (NCT06480240) has reached the putative Recommended Phase 2 Dose (pRP2D) and Phase I completion is targeted for 1H 2027.Since December 2021, OBI has been granted by Biosion, Inc. (www.biosion.com) an exclusive license to a TROP2 targeting antibody amino acid sequence in all jurisdictions except Mainland China, Hong Kong and Macau. Biosion holds exclusive rights to that antibody sequence in Mainland China, Hong Kong and Macau. OBI holds commercial rights to OBI-992 and OBI-902 in all jurisdictions except Mainland China, Hong Kong and Macau, while Biosion holds commercial rights to OBI-992 and OBI-902 in Mainland China, Hong Kong and Macau.About OBI-904OBI-904 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody specifically targeting Nectin-4 (Nectin cell adhesion molecule 4), linked to a potent topoisomerase I inhibitor payload with Drug-to-Antibody Ratio of 8 (DAR8) through OBI's proprietary GlycOBI® ADC enabling technologies, powered by a dual-function enzyme, EndoSymeOBI®, and a novel linker, HYPrOBI®. It is a potentially first-in-class and best-in-class glycan-based ADC designed to target multiple cancer types that express Nectin-4. Antitumor activity has been shown across several animal disease models, including HNSCC, CRC, TNBC, cervical and sarcoma cancers; OBI-904 has demonstrated a favorable safety profile in a repeat dose toxicity study in monkeys, and is now in the pre-IND stage of development.About OBI-201OBI-201 is a TROP2 x HER2 bispecific ADC generated by OBI GlycOBI® ADC enabling technologies conjugated with a topoisomerase I inhibitor. Notably, OBI is the first to demonstrate that HER2 and TROP2 can interact and form a protein complex on the cell surface-a groundbreaking discovery facilitated through collaboration with a specialized AI drug discovery partner. OBI-201 offers several advantages over mono-specific TROP2 or HER2 ADCs. By targeting both antigens, it broadens tumor coverage, especially in cancers with heterogeneous or low expression of either target. Dual targeting can enhance tumor selectivity, binding avidity, and internalization, improving payload delivery to cancer cells while potentially reducing toxicity to normal cells. OBI-201 may overcome resistance associated with downregulation of targets after treatment by certain monospecific ADCs.Animal studies revealed that OBI-201 demonstrated significantly superior anti-tumor activity compared to single-target ADCs in drug-resistant breast cancer models with extremely low HER2 expression. OBI-201 was able to sustain tumor growth suppression, indicating its potential to overcome multiple drug-resistance mechanisms. OBI-201 is a next-generation bispecific ADC poised to break through the limitations of single-target ADCs, potentially offering patients a more comprehensive and durable treatment option.About OBI-221OBI-221 is a Bispecific-Dual Payload ADC (BsDpADC), generated by OBI GlycOBI DUO® technologies, targeting cMET and HER3, conjugated with dual payload of MMAE and topoisomerase I inhibitor.In clinical practice, EGFR-targeted therapies have become a key strategy for treating non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) patients. However, tumors often rapidly develop resistance by upregulating cMET and HER3 that, in turn, sustain tumor growth. Moreover, high expressions of cMET and HER3 have been observed in gastric cancer, head and neck cancer, and various other solid tumors, further underscoring the unmet medical needs.To address this challenge, OBI Pharma leverages its proprietary GlycOBI DUO® platform and HYPrOBI® linker to develop a novel bispecific dual-payload antibody-drug conjugate (BsDpADC)-OBI-221. This therapeutic agent simultaneously targets cMET and HER3 while delivering synergistic cytotoxic agents, effectively combating tumor resistance and heterogeneity. This breakthrough design not only addresses an unmet medical need but also represents a forward-looking strategy for next-generation ADC development.OBI-221 holds meaningful potential to overcome resistance to existing EGFR-targeted therapies, potentially offering patients more targeted treatment options while delivering substantial clinical value.About GlycOBI®OBI has developed a unique glycan-based, site-specific ADC technology (GlycOBI®), designed in a Plug and Play format that is compatible with any antibodies, linkers, and payloads, and supports various drug-antibody ratios (DAR)(up to 16). Powered by OBI's proprietary dual-function enzymatic technology EndoSymeOBI® and its hydrophilic linker technology HYPrOBI®, GlycOBI®, a core component of OBI's Obrion™ ADC technology family, enables the generation of site-specific and homogeneous ADCs through an efficient, scalable and streamlined two-step, one-pot conjugation process under GMP conditions.During the conjugation process, GlycOBI® avoids disrupting the antibody structure and ensures that the resulting ADC retains biophysical characteristics comparable to the native antibody. In addition, OBI's linker technology improves payload conjugation efficiency and reduces the propensity for aggregation or degradation, further supporting a stable and well-controlled ADC manufacturing process. GlycOBI® has overcome limitations commonly associated with traditional ADC approaches and has demonstrated improved antitumor activity and stability in various in vivo studies. Notably, the platform supports the conjugation of both cytotoxic small-molecule inhibitors and highly hydrophobic degraders, expanding its applicability to next-generation modalities such as DACs.About GlycOBI DUO®GlycOBI DUO® is a next-generation dual-payload antibody-drug conjugate (ADC) technology built on the GlycOBI® site-specific conjugation platform and its proprietary enzymatic conjugation strategy. It enables the precise and programmable attachment of two distinct payloads to a single antibody with tunable ratios and supports high DAR ratios, including up to DAR24. By combining complementary mechanisms of action, GlycOBI DUO® is designed to enhance antitumor efficacy, address tumor heterogeneity, and improve the overall therapeutic index, with the potential to overcome resistance mechanisms associated with conventional ADCs-representing a promising advancement in next-generation ADC development.About ThiOBI®OBI has developed a novel irreversible, cysteine conjugation ADC platform (ThiOBI®) with improved stability, which can apply to any antibodies, linkers, and payloads. OBI's proprietary ThiOBI® platform including linker technologies (HYPrOBI®) can generate ADCs in different biomolecular formats, including antibody fragments, nanobodies, peptides, and proteins. Furthermore, OBI's HYPrOBI® linker technology has improved conjugation efficiency of the payload and reduced aggregation propensity and also expanded the half-life of the ADC products. ThiOBI has overcome the limitations of traditional cysteine ADCs and achieved better antitumor activity and stability in various in vivo tests.GlycOBI®, EndoSymeOBI®, ThiOBI®, HYPrOBI®, and GlycOBI DUO® are registered trademarks of OBI. Obrion™ is a trademark under registration.Forward-Looking StatementsStatements included in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about future clinical trials, results and the timing of such trials and results. Such risk factors are identified and discussed from time to time in OBI Pharma's reports and presentations, including OBI Pharma's filings with the Taiwan Securities and Futures Bureau.COMPANY CONTACT:Jukka MuhonenExecutive Director, Business DevelopmentOBI Pharma USA, Inc.1.617.821.0292jukkamuhonen@obipharma.comSOURCE: OBI Pharma USA, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年4月15日 - (亞太商訊 via SeaPRwire.com) - 品創控股有限公司（「品創控股」或「公司」，連同其附屬公司統稱為「集團」；股份代號：8066）欣然宣佈，集團全資附屬公司賽博幻境（香港）有限公司（「賽博幻境」）於今日隆重舉行《語音 AI 之 Echo 生態戰略全球啟幕盛典》，正式啟動其全球語音 AI 回聲生態系統（Echo Ecosystem，「回聲生態」）戰略，構建從語音數據採集、處理到商業應用的全鏈路閉環。此舉標誌著集團在人工智能語音數據服務領域的戰略佈局邁入全新階段，為集團深化 AI 業務轉型、打造長效增長曲線奠定堅實基礎。針對語音數據採集規模、質量與多樣性的行業困境，賽博幻境創造性推出區塊鏈遊戲與語音數據採集相結合的全新模式。用戶參與遊戲時，完成指定文本的語音錄製任務，既可享受遊戲樂趣，亦可獲得代幣激勵。該「遊戲化採集」模式，可大規模、高效率獲取覆蓋不同年齡、地域、口音與情感表達的真人語音數據，為構建多元化聲音數據庫提供穩定持續的來源。採集完成後，回聲平台透過專業清洗、標註與分類處理，將原始語音轉化為可直接用於 AI 訓練的結構化聲音數據庫。相關數據庫於 AI 數據市場以回聲代幣交易，供全球開發者及企業採購使用，形成「用戶參與採集 — 獲取代幣激勵 — 數據加工處理 — 市場交易流通 — 產業應用賦能」的完整價值鏈閉環。該模式不僅大幅降低語音 AI 開發門檻，更讓數據貢獻者、開發者及終端用戶共享語音 AI 發展所帶來的裨益。「語音 AI 不僅是技術，更是未來數字世界的入口。」賽博幻境首席執行官郭曉鵬先生在盛典上表示，「回聲生態致力於構建語音 AI 時代的基礎設施，透過去中心化的數據採集網絡和開放的聲音數據庫市場，我們將為全球 AI 開發者提供最豐富、最優質的聲音數據資源，推動語音 AI 技術在各行各業的快速落地和應用創新。」當前，人工智能技術加速滲透各行各業，人機對話已成為 AI 應用場景的核心交互方式。語音 AI 技術作為 AI 智能體不可或缺的組成部分，正成為連接人類與數字世界的入口。高品質、多元化的聲音數據庫是 AI 智能體強化訓練的核心基礎，語音 AI 技術發展已進入「數據驅動」新階段，優質聲音數據庫不僅可顯著提升語音合成的情感表現力、語音識別的場景適應性與對話系統的個性化能力，更成為語音 AI 產業發展的核心競爭力與先發優勢所在。品創控股銳意推動業務多元化佈局，把握數字經濟與人工智能產業的蓬勃商機，並憑藉前瞻性轉型，成功構建「私域電商營運 + AI 技術服務」雙輪驅動的業務架構。本次回聲生態全球啟動，是集團深化 AI 業務佈局、推動主營業務向 AI 數據服務轉型的關鍵里程碑。展望未來，集團將以賽博幻境為核心載體，持續深耕語音 AI 技術研發，拓展生態合作網絡，推動技術在智能客服、數字人、元宇宙、智能汽車等前沿領域深度融合；同時深化兩大業務協同效應，強化核心競爭力，推動業務高質量發展，把握全球 AI 產業廣闊機遇，致力為股東創造可持續長期回報。圖片說明 賽博幻境首席執行官郭曉鵬先生講解去中心化語音網絡的價值實現，彰顯品創控股推動語音 AI 技術在各行各業的快速落地和應用創新的決心。關於品創控股有限公司品創控股有限公司的使命是妥善運用公司所獲得的資本與獨特投資機會，為股東提供穩定的優渥收入與獲利。品創控股由六個主要事業部門組成，包括智能卡製造服務、電子商務、人工智能、投資服務、資源回收投資與媒體與娛樂投資，主要業務為生產及銷售智能卡、提供定製智能卡應用系統、私域電子商務平台營運、人工智能語音技術數據服務、提供財務及管理諮詢服務、廢舊金屬銷售及貿易、以及媒體與娛樂行業之投資。公司的總部位於香港，旗下控股公司與投資則遍佈大中華地區。關於賽博幻境（香港）有限公司賽博幻境（香港）有限公司是品創控股有限公司的全資子公司，專注於語音人工智能技術的研發與應用。賽博幻境致力於通過創新的生態模式，打造從數據采集、處理到商業落地的全鏈條語音AI解決方案，助力全球智能語音產業的發展。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, Apr 15, 2026 - (ACN Newswire via SeaPRwire.com) - As artificial intelligence adoption accelerates across Southeast Asia, enterprises across the ASEAN region are increasingly establishing structured AI engineering practices to move from experimentation to production-scale deployment.According to Joseph Bosco, Partner Manager, APJ - Prof Services at Databricks, organisations across ASEAN are recognising that sustainable AI adoption depends not only on advanced models but also on robust engineering foundations that ensure reliability, governance and operational scalability.“The early phase of AI adoption focused heavily on experimentation and proofs of concept,” Bosco said. “Across Southeast Asia we are now seeing a shift towards AI engineering practices that prioritise data quality, governance and production readiness.”Markets such as Singapore, Indonesia, Vietnam, Malaysia and Thailand are witnessing strong momentum in enterprise AI adoption as organisations modernise their data infrastructure and invest in advanced analytics capabilities.Industry experts note that AI engineering is becoming a critical discipline that connects AI innovation with enterprise operations. This includes building scalable data pipelines, managing machine learning lifecycle processes and integrating AI systems into business workflows.“Building a model is only one part of the challenge,” Bosco said. “The real work lies in creating reliable data pipelines, managing model lifecycle and embedding AI into operational systems.”Across ASEAN, many enterprises continue to manage complex data environments spanning legacy systems, multiple cloud platforms and software-as-a-service applications. Consolidating these fragmented data sources into unified platforms is increasingly seen as a prerequisite for scaling AI initiatives.Technology partners and consulting firms across the region are responding by developing dedicated AI engineering practices that combine expertise in data engineering, machine learning, generative AI and governance frameworks.These capabilities are already being applied across key sectors including financial services, telecommunications, and manufacturing.Bosco noted that Southeast Asia’s rapidly expanding data economies are creating a particularly dynamic environment for AI engineering talent and innovation.“As organisations across ASEAN continue to invest in data transformation, AI engineering will become an essential capability that enables enterprises to operationalise AI safely and effectively,” he said. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年4月15日 - (亞太商訊 via SeaPRwire.com) - 中國領先循環經濟產業新消費公司轉轉集團（下稱：轉轉）近日宣布，其自主研發的AI鑒定產品「AI拍圖驗真」在二手奢侈品鑒定領域取得重大突破，鑒定準確率實現了LV包袋鑒定錯誤率不足萬分之一、GUCCI包袋零錯誤的卓越表現；鑒定效率提升近900倍至「1秒出結果」。集團今年將逐步把AI鑒定拓展至CHANEL、Hermès等熱門品牌，並於未來延伸至腕表等其他二手品類，構建全品類AI鑒定矩陣。憑藉其頂尖AI鑒定能力及創新業務模式的領先優勢，轉轉同步計劃在香港設立國際業務總部，正式開啟全球化佈局。 作為中國頂尖二手交易平台，轉轉自2015年成立以來發展迅速，旗下擁有轉轉、找靚機、紅布林等多個知名二手消費品牌。當前中國二手閑置賽道備受資本與市場矚目，轉轉亦憑藉首創的二手質檢「官方驗」服務脫穎而出。集團已獲包括騰訊、小米、58集團在內的多家知名企業或投資者支持，上一輪融資估值達逾30億美元（約234億港元），去年營收總額突破200億元人民幣，擁有超過4億註冊用戶、5,000萬月活躍用戶。 （圖為北京「超級轉轉」二奢倉店）有別於以Carousell、閑魚等企業為代表的傳統C2C模式，轉轉透過成熟的C2B2C商業模式，以「平台居中、專業鑒定、品質保證」提供差異化平台服務。其首創的「官方驗」服務在對回收商品全方位嚴格檢測後，為其提供一份專屬的質檢報告並公開展示，絕大部分官方驗商品，都可享有7天無理由退貨、一年平台質保、內陸包郵等增值服務。轉轉透過標準化質檢與售後保障，例如履行「驗了再發貨」、「不滿意可退」、「驗錯了就賠」等策略，為消費者提供「所見即所得」的優質體驗。 （圖為轉轉青島智慧質檢中心）技術驅動是轉轉穩居行業領先地位的核心引擎。轉轉去年特別成立了AI事業部，三年內擬投入20億元人民幣研發AI質檢、智能匹配等工具。今年初上線的「AI拍圖驗真」，深度應用於二手奢侈品鑒定領域，系統基於海量真實商品圖片資料庫與深度學習演算法，將傳統需時15分鐘的人工鑒定大幅壓縮至「秒級鑒定」，最快1秒即可出結果，效率提升近900倍；同時在核心包袋品類的鑒定上，更創下錯誤率不足萬分之一的超高準確率（上線至今，LV包袋累計鑒定逾萬單以上，僅錯一單，錯誤率不足萬分之一；GUCCI包袋累計鑒定近3000單，實現零錯誤），徹底打破了傳統非標品交易及人工鑒定中的標準不一、效率樽頸等難題。 轉轉集團創辦人兼行政總裁黃煒表示：「轉轉集團在過去十年間通過持續的技術創新和戰略整合，確立了在中國二手交易市場的領導地位，我們深信領先的技術與質檢能力是打破二手交易壁壘的關鍵。轉轉致力引領中國的二手消費模式，不斷刷新消費者的二手消費體驗，我們對即將在香港設立國際業務總部感到振奮，亦是標誌著轉轉從中國市場邁向國際舞台的重要里程碑。」 （圖為轉轉APP內商品AI鑑定資訊）關於轉轉轉轉集團成立於2015年，是中國領先的循環經濟產業新消費公司，旗下擁有轉轉、找靚機、采貨俠、俠客匯、紅布林等多個二手電商品牌，業務覆蓋手機3C、奢侈品、圖書、潮玩等百餘種餘種品類二手商品交易，在全國佈局超過1,100多家線下門店和超過3,000人的上門回收團隊，通過人工智能質檢技術和創新的C2B2C商業模式，致力解決非標品交易的信任難題，為消費者帶來有「質價比」的二手好物。轉轉作為全國有履約二手商品交易平台的領導企業，去年已錄得超過4億註冊用戶、5000萬月活躍用戶。「技術驅動＋平台服務」為核心引擎，轉轉特設AI事業部，在國立首創二手質檢「官方驗」服務，並先後自主研發AI估價系統、AI拍圖驗真等核心技術產品，打造了二奢行業的頂尖AI鑒定能力，為全球知名熱門的奢侈品牌包袋品類提供秒級且精準的真偽鑒定，持續引領中國二手交易市場向標準化、數字化邁進。傳媒垂詢，請聯絡：轉轉集團公關部 Alan Wei：weixi@zhuanzhuan.com Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

KUALA LUMPUR, Malaysia, April 14, 2026 - (ACN Newswire via SeaPRwire.com) - Exito Media Concepts today announced the 46th Edition of the Digital Transformation Summit Malaysia 2026, convening on 23rd April 2026 at the Hyatt Regency Kuala Lumpur Midtown. The summit will bring together more than 200 C-Level executives, technology directors, and government leaders to address the strategic and operational imperatives shaping Malaysia's next phase of digital growth.Now in its 46th edition and part of a series spanning 11+ countries, the summit has established itself as one of Asia Pacific's most consequential forums for enterprise technology leadership.The Strategic Context: Malaysia's Digital Economy at a Critical JunctureMalaysia's digital economy is undergoing a structural shift. Driven by targeted government-led initiatives and accelerating enterprise adoption of artificial intelligence, the Internet of Things, and Web 3.0, organizations across every sector are fundamentally reimagining how they operate, compete, and deliver value.The opportunity is significant. Yet the path to enterprise-wide transformation demands more than technology investment — it requires navigating complex cybersecurity environments, integrating legacy infrastructure with modern digital architecture, developing organizational capabilities at pace, and embedding a culture of innovation that sustains long-term resilience. For Malaysia's business leadership, strategic clarity has never been more consequential.The Digital Transformation Summit Malaysia 2026 is designed precisely for this inflection point.Enterprise Transformation in PracticeThe business case for bold digital action is already being written across Malaysia. A leading domestic enterprise recently undertook a comprehensive digital transformation initiative — transitioning to a cloud-first infrastructure supported by advanced data analytics and AI capabilities.The results were measurable and material: automating key operational processes delivered significant gains in efficiency and organizational agility. The concurrent deployment of robust cybersecurity frameworks ensured data integrity and regulatory compliance. Simultaneously, structured workforce upskilling programmes enabled teams to perform with confidence in an evolving technology environment.The outcome: improved business performance, deeper customer engagement, and a materially stronger competitive position within Malaysia's digital economy. It is precisely this calibre of real-world insight that the Summit is built to surface and scale.Event OverviewThe 46th Edition of the Digital Transformation Summit Malaysia 2026 is part of a globally recognized series of events hosted across 11+ countries. This edition will convene more than 200 C-Level Executives, Directors, Heads of Technology, Government leaders, and digital transformation leaders from across industries.Through expert-led keynotes, panel discussions, and real-world case studies, the summit will highlight innovative strategies, emerging technologies, and actionable insights that empower organizations to drive digital growth and operational excellence.Date: 23rd April 2026Time: 09:00 AM to 05:00 PMVenue: Hyatt Regency Kuala Lumpur MidtownWebsite: https://digitransformationsummit.com/malaysia/Summit Agenda: Technology Priorities Shaping 2026Delivered through expert-led keynotes, high-impact panel discussions, and documented case studies, the Summit agenda will address the technology priorities most consequential to enterprise leaders this year:Artificial Intelligence & Machine Learning Embedding intelligent decision-making and automation across core business functions — from supply chain to customer experience to financial operations.Web 3.0 & Emerging Technologies Navigating decentralized innovation and unlocking new digital ecosystems with long-term enterprise relevance.Internet of Things (IoT) Advancing operational connectivity and efficiency across industries through integrated sensor and data infrastructure.Quantum Computing Examining the practical and strategic implications of the next frontier in computational capability.Cybersecurity & Data Protection Strengthening enterprise digital resilience against an increasingly sophisticated and expansive threat landscape.Cloud & Scalable Infrastructure Building the foundational agility, continuity, and scalability demanded by modern enterprise growth.Digital Culture & Transformation Strategy Developing the leadership frameworks and organizational behaviours that sustain transformation well beyond initial implementation.Data-Driven Decision Making Harnessing analytics to convert raw data into competitive intelligence and measurable business outcomes.About Exito Media ConceptsExito — the word for success — is both the name and the operating philosophy of one of the world's most active B2B events and media organizations. Over 16 years, Exito has built a reputation for delivering 240+ conferences annually across technology, digital transformation, cybersecurity, healthcare, and emerging enterprise sectors worldwide.Every Exito event is defined by meticulous agenda curation, access to world-class speaker communities, and a commitment to market-driven insight that translates directly into strategic value for attendees, sponsors, and partners. The result is a global platform trusted by thousands of senior executives to inform their most consequential decisions.Media ContactPrakruthi NayakaMedia and PR Executive, Exito Media ConceptsEmail: prakruthi.nayaka@exito-e.comWebsite: https://digitransformationsummit.com/malaysia/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年4月15日 - (亞太商訊 via SeaPRwire.com) - 4月13-14日，2026年世界互聯網大會亞太峰會在香港會議展覽中心舉辦。百望股份首席戰略官劉揚發表了題為《全球稅務合規：從"財稅數字化"到"中國企業商業信用基礎設施"》的主題演講，深度分享百望股份全球化戰略布局與落地進程，全面展示了百望以AI Agent重構跨境稅務合規體系、搭建中國企業商業信用基礎設施的創新實踐。本次峰會以"數智賦能 創新發展——攜手構建網絡空間命運共同體"為主題，由世界互聯網大會主辦，香港特別行政區政府承辦，香港特別行政區政府創新科技及工業局等協辦。香港特別行政區行政長官李家超出席開幕式並致辭。來自全球50餘個國家和地區的政府部門部長級官員、國際組織高級別代表、駐華使節、互聯網領軍企業代表，以及專家學者等約千名嘉賓參會。百望以商業信用模型架構為核心，築造AI能力壁壘本次世界互聯網大會的亮相，是百望股份上市以來完成AI戰略轉型後，首次在世界級行業論壇的重磅發聲，也是企業全球化戰略的一次全面公開發布。會上，百望股份宣告已完成全球化智能科技公司的全面能力准備，以商業信用模型為核心架構，正式開啟全球化發展新篇章。百望股份是本次大會中唯一一家實現垂直大模型企業級應用落地、且擁有規模化真實商業案例的企業，充分印證了在AI企業級應用賽道的領先身位，全面彰顯了百望股份核心戰略的前瞻性與正確性，驗證了以數據智能為核心、以AI Agent為抓手、以全球化布局為增長曲線的長期戰略布局的精准判斷。基於對AI Agent 時代企業級需求的深度理解，百望股份以動態商業信用模型為核心，完成了產品架構的全面升級，打造了"底層底座-能力中樞-智能執行"的完整閉環產品體系。 百望股份之能成為中國企業商業信用基礎設施的構建者，核心根基就藏在這一架構的底層設計邏輯之中。整個架構以算力平臺為底層支撐，向上搭建了數據中臺、AI中臺、能力中臺三位一體的技術中臺體系。基於交易關系、商品關系、制度關系、金融關系、雇傭關系五大維度，百望股份形成了以百望企信碼為底層底座，以百鏈、百信、百策為數據核心能力中樞，以百望百寶、百望百搭為智能執行應用的群體智能矩陣。區別於傳統財稅軟件的功能疊加模式，百望股份打造的是可生長、可擴展的智能技術底座，這也是商業信用基礎設施能夠持續迭代、適配全球多元場景的核心前提。作為一家善用數據的科技公司，百望股份始終將真實交易數據作為AI時代的核心競爭力，過去十年累計處理發票超 260 億張，沉澱了覆蓋 9600萬餘個市場主體的海量高質量真實交易底賬數據，成為企業AI 能力建設的核心燃料！百望Tax-Swift護航中企全球化征程，全面印證場景落地能力作為百望股份全球化戰略的核心場景落地產品，Tax-Swift全球虛擬稅務平臺基於沉澱10年的監管科技與規則引擎能力，完成了全球化適配與升級，為中國企業的全球化征程搭建起全鏈路的合規屏障。具體而言，Tax-Swift以AI技術為核心驅動力，構建了覆蓋全球稅務合規全流程的閉環服務體系。平臺依托全球引擎基座、發票引擎、稅務規則引擎、國家適配器四層核心架構，可自動完成多語言轉換、實時匯率校准、多格式報文轉換、電子簽名校驗、智能算稅算法、合規風險過濾、稅收優惠適配等全流程操作，實現了企業ERP系統到全球各國稅務系統的無縫直連，可深度適配全球主流稅務監管體系。目前，平臺已覆蓋10餘種主流語言、200餘種票據格式標准、3萬餘條國際財稅規則，已在多個中企出海場景落地見效。例如，某中國餐飲集團出海越南時，接入Tax-Swift平臺後，順利完成了越南當地門店的稅務合規體系搭建，實現了規模化落地。今年初，百望再度升級推出Tax-Swift Bai-Claw（全球稅務數字員工平臺），可覆蓋全球50餘個國家和地區的財稅合規需求，AI數字員工全面掌握權威財稅政策、行業知識與專業技能，可根據企業需求定制化部署，成為中企出海隨身隨行的合規哨兵。百望股份CSO劉揚在演講中表示："政策、數據、AI與全球化正在形成新的共振。交易無國界，納稅有主權，全球數字貿易正在進入主權卡位與信用卡位的全新階段。百望股份期望以本次峰會為契機，持續深化技術創新與產業實踐，以數智能力築牢中國企業出海的合規屏障，以商業信用基礎設施賦能全球貿易的高質量發展，攜手各界夥伴共同賦能國家一帶一路戰略，為構建網絡空間命運共同體貢獻力量。"隨著AI技術的持續深化與全球化布局的穩步推進，百望股份正在以技術創新打破跨境貿易的合規壁壘，為中國企業出海鋪就一條安全、高效的數字化通路，在全球數字貿易的新賽道上，書寫中國科技企業的全新篇章。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - April 14, 2026) - Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: 1D4) ("Doubleview" or the "Company") is pleased to announce that it has filed the independent National Instrument 43-101 Technical Report entitled "Preliminary Economic Assessment of the Hat Polymetallic Project, British Columbia, Canada" (the "Technical Report") on SEDAR+ at www.sedarplus.ca and it can also be viewed on the Company's website at www.doubleview.ca. The Technical Report supports the positive Preliminary Economic Assessment ("PEA") results for the Company's 100%-owned Hat polymetallic porphyry project ("Hat" or the "Project"), located in northwestern British Columbia, as announced on March 2, 2026 and clarified on March 23, 2026.The PEA demonstrates robust project economics for the Hat Project, including:NPV:After-tax NPV(5%) of C$6.73 billion and IRR of 23% at Consensus Metal PricesAfter-tax NPV(5%) of C$13.53 billion and IRR of 39% at Spot Metal PricesNPV Including scandium and the associated processing circuit:After-tax NPV(5%) of C$7.27 billion and IRR of 19% at Consensus Metal PricesAfter-tax NPV(5%) of C$14.85 billion and IRR of 32% at Spot Metal PricesThree processing scenarios were evaluated-Scenario A1 (A1) a Cu-Au-Ag-Co flotation base case using current testwork recoveries1, Scenario A2 (A2), the same base case using expected recoveries1, and Scenario B (B), a Cu-Au-Ag-Co flowsheet with an added hydrometallurgical circuit and scandium recovery circuit, with results indicating the Project is financially attractive even without the scandium component.Highlights:Robust Project Economics: The PEA demonstrates a high-margin operation with an After-Tax NPV(5%) of C$4.96 billion (A1), C$6.73 billion (A2), or C$7.27 billion (B), and an IRR of 19% (A1), 23% (A2), or 19% (B) at analyst consensus metal prices2. Using a spot-price scenario3, the Project delivers a compelling after-tax NPV(5%) of C$11.05 billion (A1), C13.53 billion (A2), or C$14.85 billion (B) and an IRR of 34% (A1), 39% (A2), or 32% (B).Sensitivity Highlight: Project economics show the greatest leverage to overall metal prices, with NPV (5%) ranging from C$3.2 billion to C$10.2 billion (IRR: 14%-32%) at ±20% on all metals; even under additional +20% CAPEX and +20% OPEX sensitivities, applied on top of a 25% contingency already embedded in the base case, all scenarios deliver IRRs of 16% or better, and Scenario B provides additional scandium oxide upside with NPV(5%) of C$6.5 billion-C$8.1 billion (IRR: 18%-20%) at ±40% metal price.Scale and Longevity: The mine plan supports a multi-decade life of 25 years at a 120,000 tonnes-per-day processing rate, underpinned by a resource base of 609 Mt at 0.43% CuEq4 in the Measured and Indicated categories and 503 Mt at 0.41% CuEq4 in the Inferred category.High-Output Production Profile B: Envisioned as a conventional large-scale open-pit operation, the Project is expected to produce an average of over 74 kt of copper, 254 koz of gold, 376 koz of silver and 2.7 kt of cobalt annually during the first 10 years, with life-of-mine (LOM) average production of 67.6 kt Cu, 217 koz Au, 348 koz Ag, 2.5 kt Co, and 128 tonnes of scandium oxide per year. (NOTE: based on publicly reported 2024 North American cobalt mine production of approximately 3,800-4,000 tonnes (Natural Resources Canada; U.S. Geological Survey), the projected cobalt output is estimated to represent approximately 69% of current regional mined supply).Strategic Importance for Critical Minerals: The Project is positioned as a primary North American source of copper, scandium, and cobalt. With approximately 2.42 billion pounds of copper, 80 million pounds of cobalt and 2,415 tonnes of scandium oxide contained5 in the Measured and Indicated categories, the Project represents an important discovery of critical minerals.Stable, Supportive Jurisdiction: Located in a premier mining district in British Columbia, the Project benefits from a stable regulatory environment. The Company is committed to engaging with local First Nations in a respectful manner and to working toward positive and constructive relationships as the Project advances.Catalyst for Development: The PEA serves as the technical foundation for an immediate transition into a Pre-Feasibility Study (PFS), providing a clear roadmap for early works and permitting activities in 2026 and 2027.Farshad Shirvani, President and CEO of Doubleview Gold Corp., commented: "The filing of the full PEA Technical Report solidifies the robust economics outlined in March. With an after-tax NPV(5%) reaching up to C$7.27 billion at consensus prices and up to C$14.85 billion at spot prices, we believe the Hat Project is emerging as a Tier 1 asset. It is a large-scale, long-life polymetallic opportunity in a premier jurisdiction with strong exposure to critical metals including copper, scandium and cobalt. We look forward to advancing this strategic asset toward pre-feasibility while continuing to unlock value from its copper, gold, scandium and cobalt potential."The Company cautions that the PEA is preliminary in nature and includes inferred mineral resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves. There is no certainty that the PEA will be realized. Mineral resources that are not mineral reserves do not have demonstrated economic viability.Qualified PersonsThe Technical Report was prepared in accordance with National Instrument 43-101 - Standards of Disclosure for Mineral Projects. The scientific and technical information contained in this news release has been reviewed and approved by the following Qualified Persons, each responsible for their respective areas of the Technical Report:Tomasz Wawruch - Geology and Mineral Resource EstimateShervin Teymouri - Mining engineering, capital and operating cost estimates, financial analysisAndrew Carter - Metallurgical testwork, recovery assumptions, and process metallurgyAndre de Ruijter - Process design, plant engineering, and process capital and operating costsFranky Li - Tailings management and tailings storage facility designJayesh Rami - Site infrastructure, civil works, access roads, and supporting facilitiesDoubleview acknowledges that the Project is located on the traditional territories of the Tahltan Nation and the Taku River Tlingit First Nation, and recognizes their enduring relationship to and stewardship of the land and waters. Doubleview is committed to respectful, transparent, and ongoing engagement with First Nations and local communities whose territories overlap the Project area and access routes, with a focus on protecting water and the environment and advancing responsible development.Readers are encouraged to review the full Technical Report on the Company's website at www.doubleview.ca and on SEDAR+ at www.sedarplus.ca for complete details, assumptions, risks, sensitivities, and qualifications.About Doubleview Gold Corp.Doubleview Gold Corp., a mineral resource exploration and development company based in Vancouver, British Columbia, Canada, is publicly traded on the TSX Venture Exchange (TSXV: DBG), the OTCQB (DBLVF), the Berlin Stock Exchange (GER: A1W038), and the Frankfurt Stock Exchange (1D4). Doubleview identifies, acquires, and finances precious and base metal exploration projects in North America, particularly in British Columbia. The Company increases shareholder value through the acquisition and exploration of quality gold, copper, cobalt, scandium, and silver properties-collectively critical minerals-and through the application of advanced, state-of-the-art exploration methods. Doubleview's portfolio of strategic properties provides diversification and mitigates investment risk.On behalf of the Board of Directors,Farshad ShirvaniPresident & CEOOn behalf of the Board of Directors,Farshad Shirvani, President & Chief Executive OfficerFor further information please contact:Doubleview Gold CorpVancouver, BC Farshad ShirvaniPresident & CEOInstitutional Line: (604) 607-5470T: (604) 678-9587E: corporate@doubleview.caNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.Certain of the statements made and information contained herein may constitute "forward-looking information." In particular references to the Mineral Resource Estimate and future work programs or expectations on the quality or results of such work programs are subject to risks associated with operations on the property, exploration activity generally, equipment limitations and availability, as well as other risks that we may not be currently aware of. Accordingly, readers are advised not to place undue reliance on forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/292439 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

喬治亞州亞特蘭大, 2026年4月14日 - (亞太商訊 via SeaPRwire.com) - 人工智慧驅動的供應鏈規劃領導者 OMP，將攜手寶潔（Procter & Gamble）出席於奧蘭多舉行的 2026 年 Gartner 供應鏈研討會暨博覽會™，展示其自主供應鏈轉型成果。這家消費品巨頭將分享如何透過 OMP 的 Unison Planning™，圍繞決策品質來建立能力、強化數據基礎並重新設計營運。此次在Gartner舞台的亮相，為雙方合作獲得的重大認可畫下句點。OMP獲選為寶潔「外部商業夥伴卓越獎」全球商業服務與IT類別的六家得主之一，此獎項旨在表彰寶潔全球逾50,000家合作夥伴網絡中展現的創新、商業影響力及營運卓越性。寶潔邁向大規模自主、決策導向規劃的歷程「One Supply」轉型資深副總裁丹妮拉·西瑪（Daniela Cima）與供應鏈平台轉型及IT規劃副總裁雷納托·斯卡尼（Renato Scaini）將分享寶潔如何重新定義自主、以決策為中心的規劃在實務中的樣貌。本場次將探討寶潔的「One Supply Chain Strategy」如何建立強化數據基礎、重新設計營運流程，並將決策品質融入整個供應鏈。目標是打造一支賦能團隊，讓成員減少耗費在例行任務上的時間，並將更多精力投入高價值的決策制定，從而提升整個價值鏈的績效。與會者將深入了解塑造寶潔下一代大規模智慧規劃的結構、文化與驅動因素，而決策速度正是這一切的核心。報名參加本場次 https://pr.report/kml0 阿斯特捷利康（AstraZeneca）於 CSCO Boardroom 主講自主規劃OMP 亦將於 5 月 4 日（週一）下午 4:00 至 4:45 舉辦一場 CSCO Boardroom 專場會議，主講嘉賓包括阿斯特捷利康全球供應鏈與策略資深副總裁 Arun Krishnan，以及 OMP 首席商業與市場官 Philip Vervloesem。本場次將探討阿斯特捷利康如何從週期性運作轉向大規模的「持續運作、以決策為核心」模式，涵蓋塑造此轉型路徑的營運模式選擇、治理架構，以及人才與技術投資。席位有限，需提前預約。預約參與 https://pr.report/kml9 親臨 OMP 展位探索決策速度OMP 將於 Gartner 供應鏈研討會暨博覽會™（5 月 5 日至 7 日，奧蘭多）期間在 322 號展位設攤，展示 Unison Planning™ 如何協助企業突破以日曆為基礎的規劃模式，邁向全天候運作的供應鏈協調。親身體驗整合式規劃如何透過最新 AI 技術的加持，提升情境建模能力、強化協作，並驅動可量化的商業成果。歡迎蒞臨 Gartner 會場與 OMP 交流，親耳聆聽 P&G 與 AstraZeneca 的實踐經驗，並探索如何加速邁向更智慧、更快速的供應鏈決策。立即聯繫我們。議程簡介主題：「OMP：P&G 如何開創自主供應鏈協調的下一時代」講者：• Daniela Cima - P&G 統一供應轉型資深副總裁• Renato Scaini - 宝洁公司供应链平台转型与IT规划副总裁时间：2026年5月5日（星期二）上午11:30 - 12:00地点：佛罗里达州奥兰多市华特迪士尼世界天鹅与海豚度假酒店如需了解OMP的下一场活动地点，请点击此处查看活动日历。解决方案与产品咨询联系 OMP+32 3 650 22 11媒体咨询基拉·珀杜（Carabiner）来源：OMP Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

賓夕法尼亞州費城, 2026年4月14日 - (亞太商訊 via SeaPRwire.com) - Datavault AI Inc.（「Datavault AI」或「本公司」） （納斯達克代碼：DVLT），一家專注於數據變現、憑證認證、數位互動及實物資產（「RWA」）代幣化技術的供應商，與 AgSensor Solutions, LLC（「AgSensor」）今日宣布，已正式簽署最終諮詢合作協議，旨在識別、評估及將高價值農業數據資產代幣化。透過此次合作，Datavault AI 將能運用 AgSensor 在農業科技領域的深厚專業知識，發掘並審核擁有大量數據資產且適合本公司專利技術——Information Data Exchange®（「IDE」）、DataScore® 及 DataValue® 區塊鏈代幣化平台——的企業。此諮詢合作夥伴關係鎖定關鍵領域，包括土壤感測、碳與永續發展數據、農業物聯網平台，以及再生農業環境、社會與治理（ESG）數據公司。透過整合 AgSensor 的專業產業知識與 Datavault AI 的變現基礎設施，雙方旨在從規模達 5 兆美元的全球農業經濟體中，創造出一類源自該領域、兼具流動性與透明度的全新數位資產¹。此舉為農業生產者與技術供應商提供了一條符合相關證券、資料隱私及反洗錢法規的合規途徑，使其能釋放資料的潛在價值，同時讓投資者得以接觸至關重要的永續發展與糧食安全指標。Datavault AI 執行長納撒尼爾·T·布拉德利（Nathaniel T. Bradley）表示：「與 AgSensor Solutions 的合作，是我們將實物資產（RWA）代幣化策略拓展至關鍵農業領域的關鍵一步。數據是現代農民的新作物，透過將我們的專利估值與交易技術應用於土壤及永續發展指標，我們正在打造一個透明的農業智慧市場。這項諮詢合作夥伴關係，將確保高價值的農業數據獲得適當認證，並為全球貨幣化做好準備。」AgSensor 共同創辦人暨執行長 Michael J. DeSa 補充道：「與 Datavault AI 合作，讓我們得以彌合先進農業感測技術與數位經濟之間的鴻溝。田間產生了海量的高品質數據，但這些數據至今仍被低估。透過此協議，我們將為業界提供將這些資產代幣化的工具，為再生農業實踐開闢新的收入來源，並提升農業數據生態系統的整體價值。」此次戰略合作聚焦於發掘擁有高價值數據資產的潛在客戶、優化農業市場的產品定位，並促進這些資產整合至 Datavault AI 的產品線中。此項交易進一步鞏固了 Datavault AI 在將多元現實世界資產代幣化方面的領導地位，並為戰略性農業數據的估值與交易樹立了標竿。1 根據聯合國糧食及農業組織（FAO）數據，全球初級農業生產總值每年超過 5 兆美元。來源：世界銀行／FAO（2024）， https://blogs.worldbank.org/en/voices/do-costs-global-food-system-outweigh-its-monetary-value 關於 Datavault AI Inc.Datavault AI™（納斯達克代碼：DVLT）是 Web 3.0 環境中以人工智慧驅動的數據體驗、資產估值及變現領域的先驅。該公司的雲端平台透過其聲學科學與數據科學兩個部門，提供全面的解決方案。Datavault AI 的聲學科學部門擁有 WiSA®、ADIO® 及 Sumerian® 等專利技術，專注於空間與多聲道無線高解析度聲音傳輸，其智慧財產權涵蓋音訊時序、同步化及多聲道干擾消除等領域。資料科學部門運用 Web 3.0 及高效能運算技術，實現體驗式數據感知、估值與安全變現。該平台服務於多個產業，包括體育與娛樂、活動與場館、生物科技、教育、金融科技、房地產、醫療保健、能源等領域。該整合開發環境（IDE）透過將實體世界物件安全地綁定至不可變更的元數據，實現數位孿生以及姓名、形象與肖像的授權，從而促進具備完整性的負責任人工智慧發展。Datavault AI 的技術套件完全可自訂，涵蓋人工智慧與機器學習自動化、第三方整合、詳細分析、行銷自動化及廣告監測。公司總部位於賓夕法尼亞州費城。更多資訊請造訪關於 AgSensor SolutionsAgSensor Solutions 是一家專注於識別與優化農業技術及數據資產的戰略顧問公司。該公司致力於將高價值的農業數據供應商與先進的變現及交易平台相連結，以推動土壤健康、碳封存及永續農業領域的創新。更多資訊請瀏覽 www.agsensorsolutions.com 。前瞻性陳述：本新聞稿包含關於 Datavault AI Inc.（「Datavault AI」、「本公司」、「我們」或「我方」）及其所處產業的「前瞻性陳述」（定義參照《1995 年私人證券訴訟改革法案》（經修訂）及其他證券法規），此類陳述涉及風險與不確定性。此類前瞻性陳述包括但不限於：關於未來事件的陳述、與 AgSensor 建立諮詢合作夥伴關係的預期效益、本公司專有 IDE、DataScore® 及 DataValue® 平台透過基於區塊鏈的代幣化來數位化農業部門所有權權益的預期適用性，以及本公司商業策略的預期營運、技術與商業成果，還有數位資產相關法規變動的預估方向與市場影響。實際結果可能因各種風險與不確定性而與這些前瞻性陳述所指稱的結果存在重大差異，包括但不限於以下事項：本公司與 AgSensor 識別、評估及將農業數據資產代幣化的能力； 本公司專有 IDE、DataScore® 及 DataValue® 平台的部署表現、時程或成功與否；市場對 Datavault AI 服務及產品需求的變化；經濟、市場或監管環境的變化；與代幣化資產相關且不斷演變的監管框架所衍生的風險； 與技術開發及整合相關的風險；以及 Datavault AI 向美國證券交易委員會（SEC）提交的文件中更詳盡描述的其他風險與不確定性，包括截至 2025 年 12 月 31 日止年度的 10-K 表格年度報告，以及 Datavault AI 不時向 SEC 提交的其他文件，該等文件可於 SEC 網站 www.sec.gov 查閱。本新聞稿中所作的前瞻性陳述僅涉及該陳述作出當日的事件。Datavault AI 概無義務更新本新聞稿中的任何前瞻性陳述，以反映本新聞稿日期之後的事件或情況，或反映新資訊或意外事件的發生，但法律另有規定者除外。Datavault AI 未必能實際實現其前瞻性陳述中所披露的計劃、意圖或預期，您不應過度依賴此類前瞻性陳述。Datavault AI 的前瞻性陳述並未反映其未來可能進行的任何收購、合併、處分、合資企業或投資所帶來的潛在影響。媒體聯絡人marketing@dvlt.ai 投資人聯絡人Edward Barger投資人關係副總裁ir@dvlt.ai ebarger@dvlt.ai 消息來源：Datavault AI Inc Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ATLANTA, GA, Apr 14, 2026 - (ACN Newswire via SeaPRwire.com) - OMP, a leader in AI-powered supply chain planning, is bringing Procter & Gamble to the Gartner Supply Chain Symposium/Xpo™ 2026 in Orlando to present its autonomous supply chain transformation. The consumer goods giant will share how it is building capabilities, enhancing data foundations, and redesigning operations around decision quality with OMP's Unison Planning™.The Gartner stage appearance caps a period of significant recognition for the collaboration. OMP was named one of six recipients of P&G's External Business Partner Excellence Award in the Global Business Services and IT category, recognizing innovation, commercial impact, and operational excellence across P&G's network of more than 50,000 global partners.P&G's journey to autonomous, decision-centric planning at scaleDaniela Cima, One Supply Transformation Senior Vice President, and Renato Scaini, Supply Chain Platform Transformation and IT Planning Vice President, will share how P&G is redefining what autonomous, decision-centric planning looks like in practice. This session will explore how P&G's "One Supply Chain Strategy" is building enhanced data foundations, redesigning operations, and embedding decision quality across its supply chain.The goal is an empowered team that spends less time on routine tasks and more time on high-value decision-making, elevating performance across the entire value chain. Attendees will walk away with concrete insights into the structures, culture, and enablers shaping P&G's next era of intelligent planning at scale, with decision velocity at the heart of it all.Sign up for the sessionAstraZeneca leads CSCO Boardroom on autonomous planningOMP is also hosting an exclusive CSCO Boardroom session on Monday, May 4 (4:00-4:45 PM), featuring Arun Krishnan, SVP of Global Supply Chain & Strategy at AstraZeneca, and Philip Vervloesem, Chief Commercial & Markets Officer at OMP. The session explores how AstraZeneca is moving away from periodic cycles toward always-on, decision-centric operations at scale, covering the operating model choices, governance structures, and talent and technology investments that shape that path. Seating is limited and available on request.Request your sessionExplore decision velocity at the OMP boothOMP will be present throughout the Gartner Supply Chain Symposium/Xpo™ (May 5 to 7, Orlando) at booth 322, demonstrating how Unison Planning™ helps organizations move beyond calendar-based planning toward always-on supply chain orchestration. See how integrated planning, enhanced by the latest AI advancements, improves scenario modeling, strengthens collaboration, and drives measurable business results.Join OMP at Gartner to hear P&G's and AstraZeneca's journeys firsthand and discover how to accelerate your path to smarter, faster supply chain decisions. Get in touch.Session at a glanceTitle: "OMP: How P&G is pioneering the next era of autonomous supply chain orchestration"Speakers:Daniela Cima - One Supply Transformation SVP at P&GRenato Scaini - Supply Chain Platform Transformation and IT Planning VP at P&GWhen: Tuesday, May 5, 2026, 11:30 AM - 12:00 PMWhere: Walt Disney World Swan and Dolphin Resort, Orlando, FLTo see where you can meet OMP next, visit their events calendar here.Solution and product inquiriesContact OMP+32 3 650 22 11Media inquiriesKira Perdue (Carabiner)SOURCE: OMP Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

PHILADELPHIA, PA, Apr 14, 2026 - (ACN Newswire via SeaPRwire.com) - Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, and AgSensor Solutions, LLC ("AgSensor") today announced the closing of a definitive consulting partnership agreement to identify, value, and tokenize high-value agricultural data assets.The partnership enables Datavault AI to leverage AgSensor's deep domain expertise in the agricultural technology sector to source and vet companies with significant data assets suitable for the Company's patented Information Data Exchange® ("IDE"), DataScore®, and DataValue® blockchain tokenization platforms. The consulting partnership targets key segments including soil sensing, carbon and sustainability data, agricultural IoT platforms, and regenerative agriculture environmental, social, and governance data firms.By integrating AgSensor's specialized industry knowledge with Datavault AI's monetization infrastructure, the companies aim to create a new class of liquid, transparent digital assets derived from the $5 trillion global agricultural economy1. This initiative provides agricultural producers and technology providers with a compliant pathway - consistent with applicable securities, data privacy, and anti-money-laundering regulations - to unlock the latent value of their data while offering investors exposure to critical sustainability and food security metrics.Nathaniel T. Bradley, CEO of Datavault AI, stated: "Our partnership with AgSensor Solutions is a pivotal step in expanding our RWA tokenization strategy into the vital agricultural sector. Data is the new crop for the modern farmer, and by applying our patented valuation and exchange technologies to soil and sustainability metrics, we are creating a transparent marketplace for agricultural intelligence. This consulting partnership ensures that high-value ag-data is properly qualified and positioned for global monetization."Michael J. DeSa, Co-Founder and CEO of AgSensor, added: "Partnering with Datavault AI allows us to bridge the gap between advanced agricultural sensing and the digital economy. There is an immense volume of high-quality data being generated in the field that remains undervalued. Through this agreement, we are providing the industry with the tools to tokenize these assets, driving new revenue streams for regenerative practices and enhancing the overall value of the agricultural data ecosystem."The strategic alignment focuses on sourcing prospects with high-value data assets, refining product positioning for the agricultural market, and facilitating the integration of these assets into Datavault AI's product lines. This transaction further solidifies Datavault AI's leadership in tokenizing diverse real-world assets and establishes a benchmark for the valuation and exchange of strategic agricultural data.1 According to the Food and Agriculture Organization of the United Nations (FAO), the gross value of global primary agricultural production exceeds $5 trillion annually. Source: World Bank/FAO (2024), https://blogs.worldbank.org/en/voices/do-costs-global-food-system-outweigh-its-monetary-valueAbout Datavault AI Inc.Datavault AI™ (NASDAQ:DVLT) is a pioneer in AI-driven data experiences, valuation, and monetization of assets in the Web 3.0 environment. The Company's cloud-based platform delivers comprehensive solutions across its Acoustic Sciences and Data Sciences divisions. Datavault AI's Acoustic Sciences division features WiSA®, ADIO®, and Sumerian® patented technologies for spatial and multichannel wireless, high-definition sound transmission, including intellectual property covering audio timing, synchronization, and multi-channel interference cancellation.The Data Science Division harnesses Web 3.0 and high-performance computing to enable experiential data perception, valuation, and secure monetization. The platform serves multiple industries, including sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy, and more.The IDE enables Digital Twins and licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity. Datavault AI's technology suite is fully customizable and includes AI and machine learning automation, third-party integration, detailed analytics, marketing automation, and advertising monitoring. The Company is headquartered in Philadelphia, PA. Learn more at www.datavaultsite.com.About AgSensor SolutionsAgSensor Solutions is a strategic consultancy specializing in the identification and optimization of agricultural technology and data assets. The firm focuses on connecting high-value agricultural data providers with advanced monetization and exchange platforms to drive innovation in soil health, carbon sequestration, and sustainable farming. Learn more at www.agsensorsolutions.com.Forward-Looking Statements: This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws) about Datavault AI Inc. ("Datavault AI," the "Company," "us," "our," or "we") and our industry that involve risks and uncertainties. Such forward-looking statements include, but are not limited to, statements regarding future events, the expected benefits of the consulting partnership with AgSensor, anticipated suitability of the Company's proprietary IDE, DataScore®, and DataValue® platforms to digitize ownership interests in the agriculture sector through blockchain-based tokenization, and expected operational, technical, and commercial outcomes of the Company's commercial strategy, and the projected direction and market impacts of regulatory changes with respect to digital assets.Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: the ability of the Company and AgSensor to identify, value and tokenize agricultural data assets; the performance, timing, or success of the deployment of the Company's proprietary IDE, DataScore®, and DataValue® platforms; changes in market demand for Datavault AI's services and products; changes in economic, market, or regulatory conditions; risks relating to evolving regulatory frameworks applicable to tokenized assets; risks associated with technological development and integration; and other risks and uncertainties as more fully described in Datavault AI's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025 and other filings that Datavault AI makes from time to time with the SEC, which are available on the SEC's website at www.sec.gov.The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Datavault AI undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. Datavault AI may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Datavault AI's forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments it may make.Media Contactmarketing@dvlt.aiInvestor ContactEdward BargerVP, Investor Relationsir@dvlt.aiebarger@dvlt.aiSOURCE: Datavault AI Inc Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

佛羅里達州坦帕市, 2026年4月14日 - (亞太商訊 via SeaPRwire.com) - Wellgistics Health, Inc. (NASDAQ:WGRX) （「Wellgistics」或「本公司」），一家領先的醫療保健科技與藥品分銷公司，今日宣布與 Kare PharmTech 的全資子公司 Kare Rx Hub, LLC（「KareRx」）簽署最終合資協議。KareRx 是一家以人工智慧（AI）為驅動的數位樞紐，致力於支援零售藥房、遠距醫療及特殊藥品計畫。此次合資協議的簽署，正式確立了先前公佈的非約束性意向書，標誌著雙方將技術平台與營運團隊整合為統一生態系統的重要里程碑，旨在加速患者獲取治療並提升藥品商業化的效率。透過將 Wellgistics Hub 技術堆疊（包含專有平台 EinsteinRx™ 及 HubRx AI™）與 KareRx 的數位樞紐整合，合併後的平台將能簡化從處方接收至履約的整個流程。Wellgistics Health 執行長 Prashant Patel 表示：「此合資企業體現了我們持續致力於打造一個整合式、技術驅動的平台，以改善處方流程各環節的協調性，並協助患者取得治療。透過結合 KareRx 的醫療提供者連結與數位互動能力，以及我們的基礎設施，我們相信此合作將提升營運效率，並協助製藥商及其他醫療保健利害關係人更有效地規劃用藥途徑。」該合資企業整合了雙方組織的臨床、營運及商業團隊，使醫療提供者、藥房與患者之間能更無縫地協調合作。透過此次整合，該平台強化了多項關鍵功能，包括資格與福利核驗、事前授權工作流程、處方箋路由，以及直接向患者配送服務。整合後的生態系統涵蓋日益擴大的全國性獨立藥房網絡、醫療服務提供者網絡及遠距醫療管道，根據第三方內部估算，其服務範圍可觸及超過 20 萬名患者。KareRx 創辦人暨執行長 Mital Panera 補充道：「KareRx 的創立初衷，是透過科技驅動的解決方案串聯醫療服務提供者、藥局與患者。這家合資企業讓我們得以運用 Wellgistics 的技術架構、製藥專業知識及營運基礎設施，進一步擴展這些能力。我們相信，整合後的平台將有助於強化各利益相關方之間的連結，並促進參與網路內治療方案的可及性。」此次合作進一步強化了「直接面向患者」（DTP）及去中心化照護模式，為製藥商提供一個將治療可及性、可負擔性與處方履行整合為單一解決方案的全面平台。透過運用人工智慧驅動的洞察力與完全整合的營運骨幹，該合資企業旨在降低治療啟動的門檻、提升用藥依從性，並對患者的治療可及性及計畫成效提供更清晰的掌握。該合資企業仍須遵循慣例的實施步驟，且無法保證營運整合的時間表或範圍，亦無法保證預期效益能否實現。有關合資協議的更多詳情，將於本公司向美國證券交易委員會提交的 8-K 表格當前報告中提供。關於 Wellgistics Health, Inc.Wellgistics Health（納斯達克代碼：WGRX）是健康資訊科技領域的領導者，將其專有的藥房調劑優化人工智慧平台 EinsteinRx™ 整合至其獲得專利的區塊鏈智慧合約平台 PharmacyChain™ 中，以優化處方藥調劑流程。該整合平台串聯了 6,500 多家藥局（「Wellgistics 藥局網絡」）及 200 多家製造商，提供批發分銷、數位處方箋傳輸、直接送達患者，以及由人工智慧驅動的樞紐服務，例如資格審核、用藥遵從性管理、新用戶註冊、事前授權，以及依需求提供的現金支付履約服務，以優化患者的用藥可及性。Wellgistics 提供端到端解決方案，旨在為美國獨立藥房恢復處方藥市場的獲取管道、透明度及信任。關於 Kare PharmTech, LLCKare Rx Hub 是一個基於人工智慧（AI）的數位樞紐，服務對象涵蓋零售藥局、遠距醫療入口網站，以及特殊藥品「輕量版」品牌產品，擁有超過 500 家醫師合作夥伴關係，以及 200 家推廣獨特特殊藥品「輕量版」產品的獨立藥局合作夥伴。Kare Rx Hub 由 Kare Pharmtech, LLC 擁有，該公司由 Kiran Patel 博士掌控。Patel 博士於 1992 年創立了 Medicaid 服務供應商 WellCare，並於 2002 年以 2 億美元售出。2007 年，Patel 博士創立了 America's 1st Choice Holdings，並收購了 Freedom Health 和 Optimum Holdings。2017年，他將 America's 1st Choice Holdings 出售予 Anthem, Inc.。Patel 博士是一位知名慈善家，曾獲《佛羅里達趨勢》雜誌評選為「年度佛羅里達人」。前瞻性陳述本新聞稿可能包含前瞻性陳述。前瞻性陳述包括有關計劃、目標、策略、未來事件或表現的陳述，以及相關假設和其他非歷史事實的陳述。當 Wellgistics Health 使用「可能」、「將」、「打算」、「應」、「相信」、「預期」、「預料」、「預測」、「估計」或類似表述，且該等表述並非僅涉及歷史事項時，即構成前瞻性陳述。這些前瞻性陳述包括但不限於關於 Wellgistics Health 策略的陳述，以及對其未來營運、前景與計畫的描述。前瞻性陳述並非對未來表現的保證，且涉及可能導致實際結果產生重大差異的風險與不確定性。其他相關因素已於 Wellgistics Health 向美國證券交易委員會（SEC）提交的文件中詳述，該文件可於 www.sec.gov 查閱。Wellgistics 媒體與投資者聯絡資訊媒體：media@wellgisticshealth.com投資者關係：IR@wellgisticshealth.com消息來源：Wellgistics Health, Inc. Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TAMPA, FLA., Apr 14, 2026 - (ACN Newswire via SeaPRwire.com) - Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced the execution of a definitive joint venture agreement with Kare PharmTech's wholly owned subsidiary, Kare Rx Hub, LLC ("KareRx"), an artificial intelligence (AI)-driven digital hub supporting retail pharmacy, telemedicine, and specialty pharmaceutical programs.The execution of the joint venture formalizes the previously announced non-binding letter of intent and represents a significant milestone in aligning both organizations' technology platforms and operational teams into a unified ecosystem designed to accelerate patient access and improve the efficiency of pharmaceutical commercialization. By integrating the Wellgistics Hub technology stack including proprietary platforms EinsteinRx™ and HubRx AI™ with KareRx's digital hub, the combined platform is positioned to streamline the prescription journey from intake through fulfillment.Prashant Patel, Chief Executive Officer of Wellgistics Health, commented, "This joint venture reflects our continued focus on building an integrated, technology-enabled platform to improve coordination across the prescription journey and support patient access to therapies. By combining KareRx's provider connectivity and digital engagement capabilities with our infrastructure, we believe this collaboration enhances operational efficiency and supports manufacturers and other healthcare stakeholders in navigating access pathways more effectively."The joint venture aligns clinical, operational, and commercial teams across both organizations, enabling more seamless coordination between providers, pharmacies, and patients. Through this integration, the platform enhances key capabilities including eligibility and benefits verification, prior authorization workflows, prescription routing, and direct-to-patient fulfillment. The combined ecosystem includes a growing national footprint of independent pharmacies, provider networks, and telehealth channels, with the ability to reach more than 200,000 patient lives based on third-party internal estimates.Mital Panera, Founder and Chief Executive Officer of KareRx, added, "KareRx was developed to connect providers, pharmacies, and patients through technology-driven solutions. This joint venture allows us to extend those capabilities by leveraging Wellgistics' technology stack, pharma expertise, and operational infrastructure. We believe the combined platform will support improved connectivity across stakeholders and facilitate access to therapies across participating networks."The collaboration further strengthens direct-to-patient (DTP) and decentralized care models, providing pharmaceutical manufacturers with a comprehensive platform that integrates access, affordability, and fulfillment into a single solution. Leveraging AI-driven insights and a fully integrated operational backbone, the joint venture is designed to reduce barriers to therapy initiation, improve adherence, and deliver enhanced visibility into patient access and program performance.The joint venture remains subject to customary implementation steps, and there can be no assurance regarding the timing or extent of operational integration or the realization of anticipated benefits. Additional details regarding the joint venture agreement will be provided in a Current Report on Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission.About Wellgistics Health, Inc.Wellgistics Health (NASDAQ:WGRX) is a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispensing journey. Its integrated platform connects 6,500+ pharmacies (the "Wellgistics Pharmacy Network") and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment as needed to optimize patient access. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust in the U.S. prescription drug market for independent pharmacies.About Kare PharmTech, LLCKare Rx Hub is an artificial intelligence (AI)-based digital hub for retail pharmacies, telemedicine portal, and specialty pharmaceutical ‘lite' branded products with over 500 physician-provider relationships, 200 independent pharmacy relationships that market unique specialty pharmaceutical ‘lite' products. Kare Rx Hub is owned by Kare Pharmtech, LLC, a company controlled by Dr. Kiran Patel. Dr. Patel founded Medicaid provider WellCare in 1992 and sold it in 2002 for $200 million. In 2007, Dr. Patel founded America's 1st Choice Holdings and acquired Freedom Health and Optimum Holdings. In 2017, he sold America's 1st Choice Holdings to Anthem, Inc. Dr. Patel is a noted philanthropist and was named Floridian of the Year by Florida Trend Magazine.Forward-Looking StatementsThis press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially. Additional factors are discussed in Wellgistics Health's filings with the SEC, available at www.sec.gov.Wellgistics Media & Investor ContactMedia: media@wellgisticshealth.comInvestor Relations: IR@wellgisticshealth.comSOURCE: Wellgistics Health, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

佛羅里達州西棕櫚灘, 2026年4月14日 - (亞太商訊 via SeaPRwire.com) - 美國馬球協會（USPA）的官方運動品牌 U.S. Polo Assn. 宣布推出《Field X Fashion》第三期，這本全球性品牌的年度雜誌今年以慶祝成立 135 週年的特別紀念版形式呈現。本期共48頁，以數位版及精裝印刷版形式在全球發行，生動呈現了品牌在2025年持續的全球成長與里程碑式成就。這本刊物將讓全球190個國家數百萬名U.S. Polo Assn.運動愛好者與消費者盡享閱讀樂趣。1. U.S. Polo Assn.《Field X Fashion》第三期——135週年紀念特刊封面2. U.S. Polo Assn. 是美國馬球協會的官方運動品牌，《Field X Fashion》第 4 頁3. U.S. Polo Assn. 2026 春季全球系列，Field X Fashion 第 7 頁《Field X Fashion》第三期捕捉了 U.S. Polo Assn. 創立 135 週年的運動靈感動能，該品牌源自 1890 年成立的美國馬球協會（USPA），並匯集了品牌在全球各地最引人入勝的故事。這期特刊亦重點呈現了全球體育賽事、時尚系列與宣傳活動、慈善計劃、永續發展里程碑、零售擴張，以及定義品牌全球影響力的關鍵合作夥伴關係。作為一個敘事平台，《Field X Fashion》持續將 U.S. Polo Assn. 源自運動的傳承，與其現代化的全球生活風格形象相連結。這本 135 週年紀念特刊，反映了過去一年品牌在提升能見度、創造深遠影響，以及持續與全球數百萬消費者、運動迷及合作夥伴互動方面的成果。本雜誌同時也深入介紹了品牌最新的全球馬球衫宣傳活動——「An Icon Born from the Game™」。「《Field X Fashion》始終是 U.S. Polo Assn. 向全球受眾傳遞品牌故事的重要媒介，」負責管理這個市值數十億美元品牌的 USPA Global 總裁兼執行長 J. Michael Prince 表示。「這本135週年紀念特刊不僅展現了我們品牌從全球運動與時尚領域到永續發展之路的非凡動能，更向過去135年來共同塑造我們傳奇的運動員、合作夥伴及消費者致敬。」「《Field X Fashion》同時也搶先揭曉了我們2026年春季全球廣告活動《馬球衫：源自賽場的經典》，這是一場對傳奇馬球衫純正運動起源及其演變為全球最歷久彌新的時尚單品之一所獻上的深情致敬，」普林斯補充道。自2023年首刊問世以來，《Field X Fashion》已發展成為一個全球內容平台，旨在吸引並激勵品牌日益壯大的運動與時尚受眾。該刊物持續專注於呈現真實且引人入勝的故事，展現U.S. Polo Assn.品牌在全球的廣度與深度，因而持續獲得業界認可。全球的顧客、運動迷、意見領袖及合作夥伴，現可於 uspoloassnglobal.com 瀏覽《Field X Fashion》第三期的數位版。紙本刊物將於全美精選的 U.S. Polo Assn. 門市、展示廳及全球活動中發行。U.S. Polo Assn. 將持續秉持這項年度傳統，透過每一期新刊，為運動、時尚及全球品牌影響力帶來嶄新視角。關於 U.S. Polo Assn. 及 USPA GlobalU.S. Polo Assn. 是美國馬球協會（USPA）的官方運動品牌，該協會成立於 1890 年，是美國規模最大的馬球俱樂部及馬球運動員組織。憑藉數十億美元的全球業務規模，以及透過超過 1,200 家 U.S. Polo Assn. 零售店和數千個其他銷售據點的全球分銷網絡，U.S. Polo Assn. 在全球 190 多個國家為男女及兒童提供服飾、配件和鞋類產品。該品牌贊助全球各大馬球賽事，包括每年於棕櫚灘的 NPC 舉辦的「美國公開馬球錦標賽®」（U.S. Open Polo Championship®），此為美國首屈一指的馬球錦標賽。透過與美國 ESPN、歐洲 TNT 和 Eurosport 以及印度 Star Sports 的歷史性合作協議，由 U.S. Polo Assn. 贊助的多項世界頂級馬球錦標賽現已透過電視轉播，讓全球數百萬體育迷首次得以親睹這項令人熱血沸騰的運動。根據《License Global》的報導，U.S. Polo Assn. 一直與 NFL、PGA 巡迴賽和一級方程式賽車並列為全球頂尖的體育授權商之一。此外，這個受運動啟發的品牌因全球業務拓展及體育內容而屢獲國際獎項肯定。憑藉其作為全球品牌的巨大成功，U.S. Polo Assn. 曾獲《富比世》、《財星》、《現代零售》及《GQ》等媒體報導，並登上雅虎財經與彭博社等全球眾多知名媒體平台。欲了解更多資訊，請造訪 uspoloassnglobal.com 並追蹤 @uspoloassn。USPA Global 是美國馬球協會（USPA）的子公司，負責管理市值數十億美元的運動品牌 U.S. Polo Assn.。USPA Global 同時管理其子公司 Global Polo，該公司是全球馬球運動內容的領導者。欲了解更多資訊，請造訪 globalpolo.com 或 YouTube 上的 Global Polo 頻道。如需更多資訊，請聯絡：Stacey Kovalsky - VP, Global PR and CommunicationsPhone +001.561.790.8036 - E-mail: skovalsky@uspagl.comKaela Drake - Senior PR & Communications SpecialistPhone +001.561.530.5300 - E-mail: kdrake@uspagl.com來源：U.S. Polo Assn. Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

West Palm Beach, FL, Apr 14, 2026 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), announces the launch of Field X Fashion, Issue 3, the global brand's annual magazine, presented this year as a special 135th Anniversary edition. Available worldwide in both digital and coffee-table print formats, the latest 48-page issue offers a dynamic look at the brand's continued global growth and milestone achievements throughout 2025. This publication will be enjoyed by millions of U.S. Polo Assn. sports fans and consumers across 190 countries worldwide.1. U.S. Polo Assn.'s third issue of Field X Fashion - 135th Anniversary Special Edition Cover2. U.S. Polo Assn. is the Official Sports Brand of the United States Polo Association, Field X Fashion page 43. U.S. Polo Assn. Spring 2026 Global Collection, Field X Fashion page 7Field X Fashion, Issue 3 captures the momentum of U.S. Polo Assn.'s 135th Anniversary of sport inspiration from the USPA, founded in 1890, bringing together the most compelling stories from across the brand's international footprint. This special edition also highlights global sporting events, fashion collections and campaigns, philanthropic initiatives, sustainability milestones, retail expansion, and key partnerships that define the brand's presence around the world.As a storytelling platform, Field X Fashion continues to connect U.S. Polo Assn.'s sport-inspired heritage with its modern, global lifestyle identity. The 135th Anniversary Special Edition reflects a year of elevated visibility, meaningful impact, and continued engagement with millions of consumers, sports fans, and partners worldwide. The magazine also provides a look into the brand's newest global polo shirt campaign, An Icon Born from the Game™."Field X Fashion continues to be an important way for U.S. Polo Assn. to share our brand story with audiences around the world," said J. Michael Prince, President and CEO of USPA Global, the company that manages the multi-billion-dollar U.S. Polo Assn. brand. "This special 135th Anniversary Edition captures the incredible momentum of our brand, from global sport and fashion to our sustainability journey, while celebrating the athletes, partners, and consumers who have helped shape our legacy over the past 135 years.""Field X Fashion also offers a sneak peek into our Spring 2026 Global Campaign, The Polo Shirt:An Icon Born from the Game, which is a powerful tribute to the legendary polo shirt's authentic sports origins and its evolution into one of the world's most enduring style essentials," added Prince.Since its 2023 debut, Field X Fashion has evolved into a global content platform designed to engage and inspire the brand's growing sport and fashion audience. The publication continues to receive industry recognition by remaining focused on delivering authentic, engaging storytelling that reflects the breadth and depth of the U.S. Polo Assn. brand worldwide.Customers, sports fans, influencers, and partners around the world can now experience the digital version of Field X Fashion, Issue 3 on uspoloassnglobal.com. Print issues will be distributed nationwide at select U.S. Polo Assn. stores, showrooms, and global events. U.S. Polo Assn. remains committed to building on this annual tradition, offering fresh perspectives on sport, fashion, and global brand impact with each new edition.About U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,200 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth and sport content. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.For Additional Information, Contact:Stacey Kovalsky - VP, Global PR and CommunicationsPhone +001.561.790.8036 - E-mail: skovalsky@uspagl.comKaela Drake - Senior PR & Communications SpecialistPhone +001.561.530.5300 - E-mail: kdrake@uspagl.comSOURCE: U.S. Polo Assn. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Apr 14, 2026 - (ACN Newswire via SeaPRwire.com) - In view of the growing and increasingly pressing demand from mainland enterprises to go global, the Hong Kong Trade Development Council (HKTDC) has launched GoGlobal Connect. This will leverage the resources of HKTDC’s 51 offices worldwide to strengthen its service offerings and facilitate more effective connections between mainland enterprises and Hong Kong’s professional service providers, while strengthening ties to explore global business opportunities and enhance Hong Kong’s role as an international platform.The GoGlobal Connect launch ceremony was held today at the HKTDC SME Service Centre. The ceremony was officiated by Algernon Yau, Secretary for Commerce and Economic Development of the Hong Kong SAR Government, and Prof Frederick Ma, Chairman of the HKTDC. It was witnessed by more than 200 enterprise representatives of mainland enterprises and Hong Kong service providers.In his welcoming remarks, Prof Ma said: “According to the World Trade Organization’s latest report, Hong Kong rose to become the world’s fifth-largest merchandise trading economy in 2025, reflecting the strong resilience of Hong Kong’s external trade and reaffirming its status as an international trade centre. This year marks the launch of China’s 15th Five-Year Plan. The HKTDC will take a proactive approach to help Hong Kong better integrate into and serve the nation’s overall development strategy. Through the newly launched GoGlobal Connect initiative, we will leverage Hong Kong’s strengths in internationally oriented professional services to lower the threshold for mainland enterprises to go global and support their steady and well‑managed overseas expansion.”In his opening remarks, Algernon Yau said that the HKTDC officially launched the GoGlobal Connect service today, along with an enhanced cross-sectoral professional services platform, further strengthening the support provided by the GoGlobal Task Force for mainland enterprises. He said: “The Task Force will continue to actively advance various initiatives, including attracting strategically valuable mainland enterprises to develop their businesses in Hong Kong. At the same time, we will continue to organise promotional and matchmaking events across different sectoral themes in Hong Kong and the mainland, and invite mainland enterprises to join overseas business missions, allowing them to gain first-hand understanding of local market situations.”Helping mainland enterprises go globalThe HKTDC’s GoGlobal Connect initiative will provide support in four key areas, by:Establishing a cross-sectoral professional services platform, which brings together professional service providers from eight key sectors to facilitate connections with mainland enterprises;Setting up GoGlobal Connect zones at HKTDC’s flagship events, where service providers can offer on-site consultations;Incorporating GoGlobal Connect elements into trade promotion activities held in the Chinese Mainland, to promote Hong Kong as a platform for enterprises going global;Leveraging the HKTDC’s global network to strengthen market connections.The GoGlobal Connect service will also be available at the HKTDC SME Service Centre.Following the launch ceremony, Yao Chenpeng, Vice President of Transfar Group, a mainland enterprise, shared the company’s plans to establish an overseas business headquarters in Hong Kong. He said that the Group’s overseas business has continued to grow in recent years, necessitating the establishment of an international management centre to handle matters such as tax planning and overseas contracts, and that the professional services available in Hong Kong are well placed to meet the company’s needs.He noted that after sharing the idea with the HKTDC in July last year, the Council promptly arranged meetings between the Group and relevant government departments, major chambers of commerce and industry associations in Hong Kong. The HKTDC also introduced the Group to Hong Kong professional service providers to help it understand the incentives and procedures for establishing operations in Hong Kong and to build business networks.Subsequently, at the Belt and Road Summit held in September last year, the HKTDC introduced professional service providers to the Group and facilitated the signing of cooperation agreements, providing practical support for the Group’s global expansion plans.A survey conducted in the Chinese Mainland by the HKTDC earlier this year among more than 2,000 mainland enterprises showed that 83% plan to leverage Hong Kong’s professional services to support their global expansion, a significant increase from 62% from a similar survey conducted in 2023. The findings underscore Hong Kong’s strengths as the preferred service platform for mainland enterprises going global.The Hong Kong SAR Government recently set up the GoGlobal Task Force and launched a thematic website in March (www.goglobal.gov.hk). The website includes a link to HKTDC’s cross-sectoral professional services platform, which provides one-stop information and professional support for mainland enterprises seeking to expand overseas via Hong Kong, helping them better leverage Hong Kong’s diverse international strengths to plan and implement their global expansion strategies. The platform has recently enhanced its service provider database and optimized the user interface. In the second half of the year, we will onboard more service providers and continue to improve the platform and matching functions to deliver more comprehensive support to mainland enterprises.Photo download: https://bit.ly/4tCTfVWThe GoGlobal Connect launch ceremony was held at the HKTDC SME Service Centre. It was attended by Algernon Yau (second left), Secretary for Commerce and Economic Development of the Hong Kong SAR Government; Prof Frederick Ma (second right), Chairman of the HKTDC; Zhou Qiang (far right), Deputy Director of the Economic Affairs Department and Head of the Trade Office of the Central Government’s Liaison Office in Hong Kong; and Sophia Chong (far left), Executive Director of the HKTDCProf Frederick Ma, Chairman of the HKTDC, delivered the welcoming remarksAlgernon Yau, Secretary for Commerce and Economic Development of the Hong Kong SAR Government, delivered the opening remarksMembers of the GoGlobal Task Force, professional bodies and organisations supporting mainland enterprises to go global, mainland officials based in Hong Kong, as well as Yao Chenpeng, Vice President of Transfar Group, attended the ceremony in support of the launchYao Chenpeng, Vice President of Transfar Group, shared the company’s latest plans to establish an overseas business headquarters in Hong KongMedia enquiriesPlease contact the HKTDC’s Communications and Public Affairs Department:Johnny TsuiTel: (852) 2584 4395Email: johnny.cy.tsui@hktdc.orgSam HoTel: (852) 2584 4569Email: sam.sy.ho@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年4月14日 - (亞太商訊 via SeaPRwire.com) - 高端新能源賽道競爭白熱化，「軟件定義汽車」從概念全面走向量產，競爭焦點也從續航、加速轉向AI能力、数据閉環與全生命週期服務。在这场深度变革中，豪華新能源車企賽力斯（601127.SH、09927.HK）2025年年報展現出難得的韌性增長：全年實現營業收入約1,648.9億元（人民幣·下同），同比增長13.6%；股歸屬于上市公司股東的淨利潤約人民幣59.6億元，連續兩年實現盈利。2025年，賽力斯旗下高端智能電動汽車品牌「問界」持續引領市場，全年交付量達42.6萬輛，同比增長10.1%，在高端新能源SUV市場份額超過20%，成爲國內市場銷量最高的中國豪華汽車品牌。其中，問界M9全年銷量逾11萬輛，穩居50萬級豪華車型年度銷量冠軍；問界M8自4月上市後，持續位居40萬級車型銷量榜首；全新問界M7在9月改款後，首季即奪得30萬級銷量冠軍。精准的大单品策略，成为品牌持续向上的核心驱动力。產品矩陣不斷完善。年内，公司相繼推出問界M9 2025款、問界M8、全新問界M7及問界M5 Ultra等多款高端智能電動汽車產品，憑藉領先的電動化、智能化技術，贏得市場的廣泛認可和用戶的喜愛。技術創新是赛力斯穿越周期的核心驅動力。2025年，公司研發投入總額達125.12億元，同比增長77.4%；研發人員增至9,019人，同比增長45.4%。累計授權專利達到8,046件，核心技術自主可控能力持續提升。高強度投入驅動核心技術接連突破。這一年，賽力斯深耕電動化與智能化核心技術，發佈了自研魔方技術平台2.0，依託平台化架構優勢，多項先進技術得以穩步量產上車，實現從「軟件定義汽車」向「AI定義汽車」的跨越；同時完成第五代2.0T超級增程技術開發，通過對超級增程系統的深度優化，將熱效率進一步推向行業頂尖。2025年公司增程器市場份額達37.5%，位居行業第一。2025年，賽力斯資本運作取得突破性進展。公司於2025年11月成功在香港聯交所主機板上市，為國際化發展及技術研發提供堅實資金支援。此外，公司通過發行股份完成對重慶龍盛新能源的收購，將核心生產工廠由租賃轉為自有資產，進一步夯實製造根基。賽力斯深知，卓越的ESG表現不僅是企業責任，更是驅動全球化、構築新質生產力的核心動能。2025年，公司在公益捐贈、鄉村振興、災害救助等方面投入顯著，全年對外捐贈約2,922萬元，並在西藏地震、四川山體滑坡等災害中快速響應，展現負責任的企業公民擔當。綠色低碳方面，公司錨定「2030年碳達峰、2045年全價值鏈近零排放」目標，推動數字化能源管理系統落地、零碳智能物流港建設、廠內光伏發電項目投運，2025 年單車碳排放強度同比下降18.92%。憑藉卓越表現，賽力斯於2025年10月榮獲MSCI（明晟）ESG最高評級AAA級。展望2026年，賽力斯將堅持大單品策略，持續鞏固高端市場領先地位，並加快海外佈局。重點以中東、中亞市場為突破口，推進產品導入及終端網路建設，同時啟動歐洲、亞太等區域的市場準備。此外，公司計畫三年內落地5,000座超充站，覆蓋高速服務區及高頻生活區，進一步完善補能生態。智能型機器人等創新業務也將加快從技術儲備走向市場落地，為長遠發展積蓄新動能。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Apr 14, 2026 - (ACN Newswire via SeaPRwire.com) - The new energy vehicle industry represents the core direction of the global automotive industry transformation and upgrading, and serves as a key lever for achieving carbon peak and carbon neutrality goals. Seres (9927.HK), as a leading luxury new energy vehicle enterprise in China, recently released its 2025 annual results. The data shows that in 2025, the Company achieved revenue of approximately RMB164.89 billion, representing a year-on-year increase of 13.63%; net profit attributable to Shareholders of the listed company amounted to approximately RMB5.96 billion, realizing profitability for two consecutive years, delivering a remarkable performance amid the industry transformation wave.Substantial Growth in Sales, Active Dividend Distribution to Reward ShareholdersIn 2025, Seres achieved substantial growth in product sales, continuing to lead the premium new energy market. The Company’s premium brand, AITO, recorded cumulative annual deliveries exceeding 420,000 units, representing a significant year-on-year increase , becoming the top-selling Chinese luxury automotive brand in the domestic market and further consolidating its market position in the luxury new energy segment.Among the brand’s models, the AITO M9 delivered over 110,000 units for the full year. Leveraging its outstanding product strength and intelligent experience, it ranked as the sales champion in the RMB500,000+ luxury car market for two consecutive years (2024 and 2025). The AITO M8 delivered over 150,000 units for the full year and has consistently held the top sales position in the RMB400,000+ vehicle segment since its launch, becoming a benchmark model in the large luxury SUV market. The AITO M7 delivered over 110,000 units for the full year, and with its precise market positioning and high cost-effectiveness, continued to gain market favor. These robust sales figures highlight Seres’ deep expertise and strong product competitiveness in the premium new energy sector, while also confirming the market’s high recognition of its product strength.In 2025, Seres actively distributed dividends to reward its Shareholders, fulfilling its corporate responsibilities through concrete actions and sharing the fruits of development with its Shareholders. The Board of Directors proposed a final dividend for the year ended 31 December 2025 of RMB0.8 per share (pre-tax), representing a total proposed cash dividend of approximately RMB1.9 billion. This reflects the Company’s sound operational strength and high accountability to shareholders, and further strengthens investors’ confidence in the Company’s future development.Continuous Increase in R&D Investment to Consolidate Foundation for Long-Term DevelopmentIn terms of R&D and innovation, Seres Group is committed to driving high-quality corporate development through technological innovation. In 2025, the Company continuously increased its R&D investment. During the reporting period, R&D expenditure reached RMB12.51 billion, up 77.4% year-on-year. Both the intensity and growth rate of R&D investment maintained industry-leading levels, providing sufficient support for technological innovation.Meanwhile, Seres Group continued to expand its R&D team. As of the end of 2025, the number of R&D personnel reached 9,019, representing a year-on-year increase of 45.4%. The R&D team featured a younger and highly educated structure, injecting a steady stream of talent vitality for technological breakthroughs.As of the end of 2025, the Company’s cumulative authorized patents reached 8,046, representing a significant increase from the previous year, covering core fields such as extended-range technology, intelligent driving and intelligent cockpit. Its core technological advantages continued to stand out, laying a solid foundation for product iteration and upgrading as well as the enhancement of market competitiveness.Overall, in 2025, against the backdrop of the industry’s transformation from "scale expansion" to “high-quality development”, Seres Group achieved an all-round breakthrough with its well-established premium product matrix, leading technological innovation capabilities and sound operational strategies. Going forward, the Company will continue to uphold its original aspiration of technological innovation, increase investment in core technology R&D, continuously optimize its product matrix, and deeply cultivate the premium new energy vehicle market, so as to make greater contributions to the high-quality development of China’s new energy vehicle industry and China’s transition from a major automobile country to an automobile powerhouse. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

賓夕法尼亞州費城, 2026年4月13日 - (亞太商訊 via SeaPRwire.com) - Datavault AI Inc.（「Datavault AI」或「本公司」） （納斯達克代碼：DVLT），一家專注於數據變現、憑證認證、數位互動及實物資產（「RWA」）代幣化技術的供應商，今日宣布將於全球集中式加密貨幣交易所Biconomy（「Biconomy」）上架其專屬的迷因幣組合及RWA代幣套件。即將推出的代幣發行，將透過 Biconomy 在東南亞的既有據點及強大的國際基礎設施，鎖定亞洲市場，其中將包含以下由 Datavault AI 獨家發行的資產：• Dream Bowl I 迷因幣 — 由 Datavault AI 發行、與 Dream Bowl XIV 相關的紀念性數位收藏品（先前已於 2025 年 12 月 11 日公告）• Dream Bowl II 迷因幣 — 與 NFL Alumni Health 合作發行的後續股東股息代幣（先前已於 2025 年 12 月 29 日公告）• Josh Gibson 迷因幣 — 為紀念棒球傳奇人物 Josh Gibson 而推出的 NIL 主題紀念數位收藏品，由 Josh Gibson 基金會協同開發（先前已於 2026 年 2 月 20 日公告）• 專有 RWA 穩定幣——涵蓋精選 RWA 資產此計畫旨在為 Datavault AI 的社群驅動迷因資產及其機構級代幣化產品，提供流動性與廣泛的流通管道。值得注意的是，與 Datavault AI 先前宣布與 Triton Geothermal LLC 簽訂的數百萬美元代幣化服務協議相關的 TRITON 代幣（該協議已於 2025 年 11 月 17 日公布），目前已在 Biconomy 平台正式上線並活躍交易（可透過 biconomy.com/exchange/TRITON_USDT 進行交易）。如先前所披露，Datavault AI 擔任 Triton 旗下經美國能源部驗證之地熱能源資產在實物資產（RWA）數位化、估值及結構化變現方面的獨家技術供應商；本公司將獲得最高 800 萬美元的代幣化費用，該費用與 Triton 計劃發行的 1.25 億美元數位代幣相關，並將持續獲得相當於 Triton 於發行後所收取之所有數位代幣交易手續費 5% 的分成。TRITON 在 Biconomy 上的活躍交易，展現了 Datavault AI 代幣化流程從協議簽署到次級市場流動性實現的實際進展——隨著更多資產接入 Biconomy 並最終接入 Datavault 資訊數據交易所，本公司預期其更廣泛的迷因幣、RWA 穩定幣及智能合約代幣組合也將遵循此路徑。Biconomy 成立於 2019 年，服務遍及 180 多個國家的 1,000 萬名用戶及機構，交易量始終位居全球交易所前 20 至 30 名，日均交易量介於 20 億至 28 億美元之間。該平台提供數百種交易對，並維持業界領先的安全性，其中 98% 的資產存放於冷儲存中。此舉將推動 Datavault AI 進一步開發「Datavault AI 資訊數據交易所」，該平台將由納斯達克金融框架（Nasdaq Financial Framework）提供技術支援。透過善用 Biconomy 經實證的流動性、用戶基礎及亞洲市場領導地位，本公司正致力強化代幣採用率、流動性深度及合規的跨境分銷——這些皆為可擴展、機構級數位資產基礎設施的基石。Datavault AI 執行長 Nathaniel T. Bradley 表示：「在 Biconomy 上的這些上市，對我們的迷因幣投資組合及實物資產（RWA）生態系統而言，代表著一個重要的里程碑。此次推出的資產將與我們的專利『資訊數據交易所®』（Information Data Exchange®）、『國際元素交易所™』（IEE）、專注於體育領域的國際 NIL 交易所，以及『美國政治交易所™』（APE）相輔相成。我們預期，所有這些平台都將受益於 Biconomy 龐大的日交易量及其針對亞洲市場的觸及能力，從而為我們的代幣發行及不斷擴展的迷因幣投資組合策略帶來可觀的流動性並加速其採用。」關於 Datavault AI Inc.Datavault AI TM（納斯達克代碼：DVLT）在 Web 3.0 環境中，於人工智慧驅動的數據體驗、資產估值及變現領域處於領先地位。該公司的雲端平台提供全面的解決方案，其聲學科學與數據科學部門均以協作為核心。Datavault AI 的聲學科學部門擁有 WiSA®、ADIO® 及 Sumerian® 等專利技術，以及業界首創的基礎空間與多通道無線高解析度聲音傳輸技術，其智慧財產權涵蓋音訊時序、同步及多通道干擾消除等領域。數據科學部門則運用 Web 3.0 與高效能運算的優勢，提供體驗式數據感知、估值及安全變現的解決方案。Datavault AI 的平台服務於多個產業，包括運動與娛樂、活動與場館、生物科技、教育、金融科技、房地產、醫療保健、能源等領域的高效能運算軟體授權。Information Data Exchange® 透過將實體世界中的物件安全地連結至不可變更的元數據，實現數位孿生以及姓名、肖像與形象的授權，從而促進具備完整性的負責任人工智慧發展。該公司的技術套件完全可自訂，提供基於人工智慧與機器學習的自動化功能、第三方整合、詳細分析與數據、行銷自動化以及廣告監測。該公司總部位於賓夕法尼亞州費城。欲進一步了解 Datavault AI，請造訪 https://datavaultsite.com。前瞻性陳述本新聞稿包含關於 Datavault AI Inc.（以下簡稱「Datavault AI」、「本公司」、「我們」或「我方」）及其所處產業的「前瞻性陳述」（定義參照經修訂的《1995 年私人證券訴訟改革法案》及其他證券法規），此類陳述涉及風險與不確定性。在某些情況下，您可以透過以下詞彙識別前瞻性陳述，例如「可能」、「或許」、「將」、「應」、「預期」、「計劃」、「預料」、「能夠」、「意圖」、「目標」、 「預測」、「考慮」、「相信」、「估計」、「預測」、「潛在」、「目標」、「宗旨」、「尋求」、「可能」、「即將」或「持續」等詞彙，或這些詞彙的否定形式，或其他涉及本公司預期、策略、計劃或意圖的類似詞彙或表述。未使用上述詞彙並不表示該陳述不具前瞻性。此類前瞻性陳述包括但不限於：關於未來事件的陳述；本公司迷因幣投資組合及 RWA 代幣套件於 Biconomy 上市的預期效益，包括預期流動性、交易量、代幣採用率，以及在亞洲及國際市場的市場分佈；本公司預期其更廣泛的數位資產投資組合（包括未來發行的迷因幣）實物資產（RWA）穩定幣及其他代幣化產品將逐步納入 Biconomy 平台；TRITON 代幣及其他於 Biconomy 上市的 Datavault AI 數位資產的預期交易表現、流動性及交易量； 本公司根據先前披露的《代幣化服務協議》，持續參與 Triton Geothermal LLC 所收取的交易手續費；IDE 的預期開發、推出及商業化進程，包括其預期時程、功能及機構級能力； IDE 及其相關交易所的預期推出、營運及商業表現；利用 Biconomy 的用戶群、日交易量、流動性基礎設施及亞洲市場佈局，以推動本公司代幣發行之採用與分發，並擴展迷因投資組合策略所預期帶來的效益；以及本公司的商業策略、長期目標及商業化計畫，均必然基於估計與假設，儘管本公司及其管理層認為該等估計與假設合理，但本質上仍存在不確定性。實際結果可能因各種風險及不確定性而與這些前瞻性陳述所指明的結果存在重大差異，包括但不限於以下內容：與本公司能否實現 Biconomy 上市預期效益相關的風險，包括預期的流動性、交易量及代幣採用率；與 Biconomy 的上市安排可能無法在亞洲或國際市場實現預期市場滲透率或分銷範圍的風險；與 TRITON 代幣、Dream Bowl I、Dream Bowl II、Josh Gibson Coin、RWA 穩定幣以及其他在 Biconomy 平台上的 Datavault AI 數位資產之交易表現、流動性及市場價格，包括交易量可能未達預期的風險；與本公司能否在預期時程內（或根本無法）成功開發、推出及營運 IDE（包括其相關交易所）有關的風險； 本公司交易所平台可能無法達到預期交易量、用戶採用率或營收水準的風險；與數位資產市場（包括迷因幣市場）的波動性及不可預測性相關的風險，該等市場可能出現與本公司營運表現無關的重大價格波動；本公司依賴第三方平台（包括 Biconomy）進行數位資產掛牌、交易及託管所衍生的風險； Triton Geothermal LLC 可能無法完成其計劃中的數位代幣發行，或本公司可能無法收取預期的代幣化費用或交易手續費分成之風險；針對數位資產、加密貨幣交易所或跨境代幣分發之監管變動，可能對 Datavault AI 營運所在市場造成負面影響之風險；與美國、東南亞及其他司法管轄區適用於代幣化資產之監管框架演變相關之風險； 市場對 Datavault AI 服務及產品的需求變化；經濟、市場或監管環境的變化； 與技術開發及整合相關的風險；以及 Datavault AI 向美國證券交易委員會（「SEC」）提交的文件中更詳盡所述的其他風險與不確定性，包括其截至 2025 年 12 月 31 日止年度的 10-K 表格年度報告，以及 Datavault AI 不時向 SEC 提交的其他文件。謹此提醒您，請勿過度依賴此等前瞻性陳述，該等陳述僅反映截至本文件日期之情況。Datavault AI 概無義務更新本新聞稿中所載之任何前瞻性陳述，以反映本新聞稿發布日期之後發生的事件或情況，或反映新資訊或意外事件的發生，惟法律另有規定者除外。Datavault AI 可能無法實際實現其前瞻性陳述中所披露的計劃、意圖或預期，您不應過度依賴此類前瞻性陳述。Datavault AI 的前瞻性陳述並未反映其未來可能進行的任何收購、合併、處分、合資企業或投資所帶來的潛在影響。媒體聯絡人marketing@dvlt.ai投資人聯絡人Edward Barger投資人關係副總裁ir@dvlt.ai(503) 615-7700消息來源：Datavault AI Inc Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com